[go: up one dir, main page]

WO2003016525A9 - Process for producing alcohol from starch - Google Patents

Process for producing alcohol from starch

Info

Publication number
WO2003016525A9
WO2003016525A9 PCT/JP2002/008234 JP0208234W WO03016525A9 WO 2003016525 A9 WO2003016525 A9 WO 2003016525A9 JP 0208234 W JP0208234 W JP 0208234W WO 03016525 A9 WO03016525 A9 WO 03016525A9
Authority
WO
WIPO (PCT)
Prior art keywords
yeast
amylase
cell surface
starch
plasmid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2002/008234
Other languages
French (fr)
Japanese (ja)
Other versions
WO2003016525A1 (en
Inventor
Hideki Fukuda
Akihiko Kondo
Atsuo Tanaka
Mitsuyoshi Ueda
Eiichi Satoh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kansai Chemical Engineering Co Ltd
Original Assignee
Kansai Chemical Engineering Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2002/001980 external-priority patent/WO2003016524A1/en
Application filed by Kansai Chemical Engineering Co Ltd filed Critical Kansai Chemical Engineering Co Ltd
Priority to JP2003521834A priority Critical patent/JP4189317B2/en
Publication of WO2003016525A1 publication Critical patent/WO2003016525A1/en
Publication of WO2003016525A9 publication Critical patent/WO2003016525A9/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/06Ethanol, i.e. non-beverage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00Technologies for the production of fuel of non-fossil origin
    • Y02E50/10Biofuels, e.g. bio-diesel

Definitions

  • the present invention relates to a method for producing ethanol from starch. More specifically, the present invention relates to a method for producing ethanol using yeast which presents glycoamylase on the cell surface and secretes ⁇ -amylase. Alternatively, the present invention relates to a method for producing ethanol using yeast that displays dalcoamylase and ⁇ -amylase as a fusion protein on the cell surface. More specifically, the present invention relates to a method for producing ethanol from uncooked starch using the yeast as described above. Background art
  • biomass as a new energy resource has attracted attention in recent years.
  • Cellulose and starchy substances of plant origin are the most abundant and available biomass resources.
  • ethanol produced from starch resources is attracting attention as a renewable environmentally-friendly energy resource, and the demand for it is expected to increase in the future.
  • Ethanol production from starch by the current fermentation method is carried out in two stages: starch is steamed, starch is saccharified by treatment with koji mold that secretes amylase, and fermentation is performed by fermentation. . This is because yeast does not have amylases and therefore cannot degrade and saccharify starch.
  • an object of the present invention is to construct a yeast capable of producing ethanol directly and more efficiently from starch, and to provide a method for producing ethanol using the yeast.
  • the present inventors transformed yeast to display dalcoamylase on the cell surface and to secrete or display ⁇ -amylase on the cell surface. As a result, it was found that ethanol productivity was significantly improved, and the present invention was completed. Accordingly, the present invention provides a yeast which displays dalcoamylase on the cell surface and secretes ⁇ -amylase.
  • the dalcoamylase is presented via a GPI anchor.
  • the dalcoamylase is presented as a fusion protein with a sugar chain binding protein domain that does not have a GP I anchor attachment recognition signal sequence.
  • the present invention also provides a darcoamylase and ⁇ -amylase fusion protein
  • a yeast which is displayed on a cell surface as a fusion protein with a sugar chain binding protein domain having no G ⁇ I anchor attachment recognition signal sequence, wherein the dalcoamylase is fused to one end of the domain, and the other end is the yeast.
  • Hi-amylase Provide yeast that has been fused.
  • the sugar chain binding protein domain is a portion containing at least an aggregation functional domain of a GP I anchor protein.
  • the GPI anchor protein is an aggregated protein.
  • the aggregated protein is a protein selected from the group consisting of FL01, FL02, FL04, FL05, FLO9, FLO10, and FLO11.
  • the ⁇ -amylase is from Streptococcus bovis 148.
  • the present invention also provides a method for producing alcohol, comprising a step of culturing the yeast in a medium containing starch.
  • the starch is uncooked.
  • FIG. 1 is a schematic diagram showing the construction of a plasmid pAAl2 that presents ⁇ -amylase on the cell surface by a GPI anchor.
  • FIG. 2 is a schematic diagram showing the construction of plasmid pSAA11 that secretes ⁇ -amylase.
  • FIG. 3 is a schematic diagram showing the construction of plasmid pSGAl1, which secretes dalcoamylase.
  • FIG. 4 is a schematic diagram of the plasmid BAA1.
  • FIG. 5 is a schematic diagram of the plasmid pSBAA2.
  • FIG. 6 is a graph showing changes over time in starch concentration and cell density when various recombinant yeast cells are cultured under aerobic conditions.
  • Figure 7 shows the results of alcohol fermentation using uncooked corn starch medium. It is a graph which shows a time-dependent change of the starch density
  • FIG. 8 is a graph showing the time-dependent changes in the starch concentration and the ethanol concentration in the medium when various concentrations of non-steamed corn starch are used.
  • FIG. 9 is a graph showing the time-dependent changes in the starch concentration and the ethanol concentration in the medium when various concentrations of yeast YF207 / [pGA11, pSBAA2] were used.
  • FIG. 10 is a plate photograph showing the results of a plate assay on glucoamylase activity.
  • FIG. 11 is a photograph of a plate showing the results of plate assay for ⁇ -amylase activity.
  • dalcoamylase refers to an exo-type hydrolase that separates a glucose unit from the non-reducing end of starch.
  • the origin is not limited as long as it has such an activity.
  • darcoamylase derived from molds such as Rhizopus and Aspergillus is used.
  • darcoamylase derived from Rhizopu s oryzae is preferably used.
  • ⁇ -amylase refers to an endo-type enzyme that hydrolyzes ⁇ 1,4-darcoside bonds of starch.
  • the source of the activity is not limited as long as it has this activity.
  • ⁇ -amylase derived from animals (such as saliva and kidney), plants (such as malt), and microorganisms is used.
  • alpha-amylase force derived from a microorganism s preferred include those such as from Streptococcus bovis.
  • ⁇ -amylase derived from Streptococcus bovis is particularly preferred when uncooked starch is used as a carbon source.
  • the first yeast of the present invention is yeast transformed to present dalcoamylase on the cell surface and secrete ⁇ -amylase.
  • Such a yeast can be obtained by introducing into a yeast D ⁇ ⁇ ⁇ ⁇ recombined to display glucoamylase on the cell surface and D ⁇ ⁇ ⁇ ⁇ recombined to secrete ⁇ -amylase. , can get.
  • the second yeast of the present invention is a yeast transformed to display dalcoamylase and ⁇ -amylase as a fusion protein with a sugar chain binding protein domain on a cell surface.
  • Such yeasts can be obtained by introducing into the yeast a recombinant DNA that displays the darcoamylase, ⁇ -amylase, and carbohydrate-binding protein domains as a single fusion protein on the cell surface.
  • the method of presenting the enzyme on the cell surface includes: (a) a method of presenting the enzyme to the cell surface via a GPI anchor of a cell surface-localized protein; and (b) a method of displaying the sugar on the cell surface-localized protein.
  • any of the methods (a) and (b) may be used.
  • Cell surface localization proteins that can be used include yeast sex aggregation proteins ⁇ - or a-agglutune, FLO proteins (eg, FL01, FLO2, FL04, FL05, FL09, FLO10, and FLOl 1), alkaline phosphatase And the like.
  • Genes encoding proteins localized on the cell surface by the GPI anchor include, in order from the N-terminus, a secretory signal sequence, a cell surface localized protein (sugar chain binding protein domain), and a GPI anchor attachment recognition signal sequence. Each has an encoding gene.
  • the cell surface localization protein (sugar chain binding protein) expressed from this gene in the cell is guided out of the cell membrane by a secretory signal, and the GPI anchor attachment recognition signal sequence is selectively cleaved. It is fixed to the cell membrane by binding to the GPI anchor of the cell membrane via the terminal part. Thereafter, the root of the GPI anchor is cut off by PI-PLC, incorporated into the cell wall, fixed to the cell surface, and presented to the cell surface.
  • the GPI anchor refers to a glycosylphosphatidylinositol (GPI) ethanolamine phosphate-6 mannose ⁇ 1-2 mannose 1-6 mannose a 1-4 darcosamiso a 16 inositol phospholipid basic structure
  • PI-PLC refers to phosphatidylinositol-dependent phospholipase C.
  • the GPI anchor attachment recognition signal sequence is a sequence that is recognized when the GPI anchor binds to a cell surface localization protein, and is usually located at or near the C-terminus of a cell surface localization protein.
  • the GPI anchor attachment signal sequence for example, the sequence of the C-terminal part of yeast agglutin is preferably used.
  • a GPI anchor attachment recognition signal sequence is included on the C-terminal side of the sequence of C-terminal 320 amino acids from the C-terminal of the ⁇ -agglutene. DNA sequences encoding are particularly useful.
  • the structural gene encoding a cell surface localized protein the cell surface localized protein Recombinant DNA that displays the target enzyme on the cell surface via a GPI anchor by replacing the sequence of all or part of the structural gene encoding the target enzyme with the sequence of the structural gene of the target enzyme Is obtained.
  • a glucoamylase gene is used as the structural gene of the enzyme of interest, a recombinant DNA that presents dalcoamylase on the cell surface via a GPI anchor can be obtained.
  • the sugar chain-binding protein domain has a plurality of sugar chains, and the sugar chains interact with or are entangled with the sugar chains in the cell wall. It is possible to stay.
  • a sugar chain binding site of lectin, lectin-like protein and the like can be mentioned.
  • a typical example is the aggregation functional domain of a GPI anchor protein.
  • the aggregation functional domain of the GPI anchor protein refers to a domain that is located on the N-terminal side of the GPI anchoring domain, has a plurality of sugar chains, and is considered to be involved in aggregation.
  • the enzyme is displayed on the cell surface by binding the cell surface localized protein (aggregation function domain) with the target enzyme.
  • the enzyme is bound to the N-terminal side of the cell surface localized protein (aggregation functional domain)
  • the enzyme is bound to the C-terminal side
  • the N-terminal side is bound to both the C-terminal side and the C-terminal side.
  • DNA encoding a secretory signal sequence—structural gene of the enzyme of interest Structural gene encoding a single cell surface localization protein (aggregation function domain)
  • DNA encoding a secretory signal sequence a structural gene encoding a cell surface localization protein (aggregation function domain) —a structural gene of an enzyme of interest;
  • a recombinant DNA that displays dalcoamylase on the cell surface using the sugar chain binding protein domain can be obtained.
  • a secretory signal sequence of a protein localized on the cell surface may be used, or another secretory signal sequence capable of directing the expressed enzyme to the outside of the cell may be used. Is also good.
  • a secretory signal sequence for dalcoamylase, a secretory signal sequence for yeast ⁇ - or a-agglutin, and a secretory signal sequence for lipase are preferably used. If the enzyme activity is not affected, part or all of the secretory signal sequence and prosequence may remain at the N-terminus after cell surface display.
  • a recombinant DN DN in which a structural gene of a target enzyme such as dalcoamylase or ⁇ -amylase is linked to DNA encoding the above-mentioned secretory signal sequence may be introduced into yeast.
  • DNAs containing the above-described various sequences can be performed by those skilled in the art using conventional techniques. For example, binding of the secretory signal sequence to the structural gene of dalcoamylase or human amylase is performed using site-directed mutagenesis. I can. By using this method, accurate secretory signal sequence cleavage and expression of active dalcoamylase or monoamylase are possible.
  • the above sequence of interest is preferably incorporated into a vector.
  • a shuttle vector with Escherichia coli is preferable.
  • it has a replication origin (Or i) of 2 m plasmid of yeast and a replication origin of ColEl, and further has a yeast replication origin.
  • it has a selection marker (eg, drug resistance gene, TRP, LEU2, etc.) and an E. coli selection marker (eg, drug resistance gene).
  • the dalcoamylase or ⁇ -amylase structural gene it is desirable to include so-called regulatory sequences such as an operator, a promoter, a terminator, and an enhancer that regulate the expression of this gene.
  • regulatory sequences such as an operator, a promoter, a terminator, and an enhancer that regulate the expression of this gene.
  • the plasmid pYGA2270 or pYE 22m containing the GAPDH (glyceraldehyde 3, monophosphate dehydrogenase) promoter and the GAPDH terminator, or the UPR-ICL (isoquenate lyase upstream region) sequence
  • a plasmid pWI3 containing a Term-ICL (terminator region of isocitrate lyase) sequence.
  • a DNA encoding a secretory signal sequence between the sequence of the GAP DH promoter and the GAP DH terminator of the plasmid pYG A2270 or p YE 22 m By inserting a sequence that combines the sequence of the darco amylase or ⁇ -amylase structural gene and the sequence encoding 320 amino acids from the C-terminus of ⁇ -agglutinin, a binder for introduction into yeast can be produced. Is done.
  • Vectors are available in multicopy and chromosomal integration types. Which type of vector is to be incorporated into which gene may be appropriately determined by those skilled in the art.
  • the enzyme displayed on the cell surface and the secreted enzyme may be incorporated in the same vector, PT / JP02 / 08234
  • Each may be integrated into a different vector.
  • any yeast can be used as long as it can utilize sugar to have alcohol fermentation ability.
  • Non-aggregating and flocculating yeasts are used.
  • Cohesive yeasts are preferred because they can be separated easily after the reaction, or because they can be fixed easily and can be subjected to a continuous reaction.
  • the non-aggregating yeast is not particularly limited, and examples thereof include Saccharomyces ce revisiae MT8-1.
  • yeast of flocculation examples include Saccharomyces diastaticus ATCC60715 and ATCC60712, Saccharomyces cerevisiae IF01953, CG1945 and HF7C. Further, a new flocculant yeast may be constructed. For example, as shown in “Preparation of Experimental Materials” in Examples below, flocculent yeast was produced according to the method of MD Rose et al. (Methods in Yeast Genetics, 1990, Cold Spring Harbor Laboratory Press, Cold Spring Haroor, NY). From the diploid obtained by conjugation of ATCCS0712 with the non-aggregating yeast W303-IB, it is possible to obtain an aggregating yeast YF207 and a yeast having properties equivalent thereto.
  • the flocculent yeast strain YF207 obtained by the present inventors has excellent plasmid retention stability, and has very high fermentation ability. Therefore, when the flocculent yeast strain YF207 which is dal coamylase displayed on the cell surface and is recombinantly secreted to secrete ⁇ -amylase is used, the productivity of ethanol is extremely high.
  • a yeast which presents the glucoamylase of the present invention to the cell surface and secretes ⁇ -amylase, or a yeast which presents dalcoamylase and ⁇ -amylase to the cell surface as a fusion protein (hereinafter referred to as the yeast of the present invention and ) Can be obtained by simultaneously or separately introducing recombinant DNA (vector) having DNAs encoding the above enzymes into yeast.
  • Methods for introducing DN ⁇ include transformation, transduction, transfection, co-transfection, and electoral poration. Examples include a transformation method using lithium acetate and a protoplast method.
  • Yeast into which the recombinant DNA (vector) has been introduced is selected with a selectable marker (eg, TRP, URA).
  • the presence of dalcoamylase or ⁇ -amylase on the cell surface can be confirmed after washing the cells, for example, by an immunoantibody method using an anti-glucoamylase antibody or an anti-amylase antibody and a FITC-labeled antibody. .
  • the secretion of ⁇ -amylase can also be confirmed in a culture solution from which cells have been removed, for example, by an immunoantibody method using an anti-amylase antibody.
  • the yeast of the present invention may be immobilized on a carrier. When fixed, it is convenient for use in repeated batch or continuous fermentations.
  • a method usually used for yeast by those skilled in the art is applied.
  • the immobilized yeast can be used as a so-called bioreactor by being attached to a carrier and filled in a column that is cultured in a suspended state. Even if the fermentation is repeated continuously or in batches (batch), the activity of the yeast decreases or the dead yeast is eliminated, so that the yeast activity does not decrease and the yeast is effective. Can be used for
  • the yeast of the present invention is first cultured under aerobic conditions to increase its number.
  • the medium may be a selective medium or a non-selective medium.
  • This yeast can be grown using starch as a carbon source, and the concentration of starch in the culture medium during culturing is preferably about 1 to about 10 g / l, more preferably about 2 to about 6 g when soluble starch is used. g / l, most preferably about 4 g / l.
  • the concentration of starch in the medium is about 1 to about 50 g / l, preferably about 2 to about 40 g / 1, and more preferably about 10 to about 20 g / l.
  • the pH of the culture medium during the culturing is preferably about 4.0 to about 6.0, most preferably about 5.0. In medium during aerobic culture PT / JP02 / 08234
  • the dissolved oxygen concentration of 12 is preferably about 0.5 to about 6 ppm, more preferably about 1 to about 4 ppm, and most preferably about 2.0 ppm.
  • the temperature during the culturing is about 20 to about 45 ° C, preferably about 25 to about 35 ° C, and most preferably about 30 ° C.
  • the culturing is preferably performed until the cell concentration reaches 10 g / l or more.
  • the yeast of this effort is fermented under anaerobic conditions to produce ethanol.
  • Examples of the form of this fermentation step include a batch (batch) step, a fed-batch batch step, a repeated batch step, a continuous step, and the like, and any of these may be used.
  • the batch fermentation process is a closed fermentation method performed by inoculating yeast into a medium previously placed in a fermenter.
  • fermentation is performed while supplying a nutrient medium to the batch process, but the target product is not extracted until a certain time.
  • the repeated batch process is a process in which the above batch process is repeated. Specifically, after the first batch process, the operation of separating the culture medium and yeast, extracting the culture medium, and then adding a fresh culture medium to perform the fermentation step is repeatedly performed.
  • the continuous fermentation process is a process in which fresh medium is continuously supplied to the fermenter while simultaneously extracting the medium containing the product (ie, ethanol) from the fermenter.
  • the starch concentration in the medium is preferably about 40 to about 150 g / l.
  • the starch concentration is more preferably from about 50 to about 120 g / l, most preferably about 60 g / l.
  • the added starch concentration is preferably maintained at about 40 to about 300 g / l, more preferably about 60 to about 250 g / l, most preferably about 200 g / l.
  • the starch concentration in the medium is about 50 to about 500 g / l, preferably about 50 to about 400 g / l, and more preferably about 150 to about 250 g / l.
  • the pH of the medium during fermentation is preferably from about 4.0 to about 6.0, most preferably about 5.0. ⁇
  • the dissolved oxygen concentration in the medium during aerial fermentation varies depending on the yeast used as the host, Preferably it is less than about 1.0 ppm, more preferably less than about 0.1 ppm, most preferably less than about 0.05 ⁇ .
  • the temperature during fermentation is about 20 to about 45 ° C, preferably about 25 to about 35 ° C, and most preferably about 30 ° C.
  • the initial cell concentration in the medium during anaerobic fermentation (charge concentration), type of yeast, the force varies by as starch concentration of culture ground S, preferably early 0D 6. . Is from 10 to 300, more preferably from 30 to: L00.
  • the medium containing ethanol is withdrawn from the fermenter, and ethanol is isolated by a separation step commonly used by those skilled in the art such as a centrifugal separator and a distillation operation.
  • Saccharomyces diastaticus ATCC60712 (MATa leu2-3, 1 12 his2 lys2 stal FL08), which is an aggregating yeast, and W303-IB ( ⁇ ⁇ ura3-52 trpl A 2 leu2—3, 112 his3— 11, a non-aggregating yeast ade2—1 canl-100) and according to the method of MD Rose et al., supra, a new aggregating strain of tributofan auxotrophy, YF207 (MATa ura3-52 trpl ⁇ 2 his ade2-1 canl-). 100 stal FL08).
  • yeast Saccharomyces cerevisiae MT 8-1 (MATa ade his3 leu2 trpl ura3) (Tajima et al., Yeast, 1: 67-77, 1985) Used as yeast.
  • the multicopy plasmid pGAl1 which presents the dalcoamylase from Rhizopus oryzae on the cell surface, is described by the inventor Tanaka Ope Ueda et al. (Appi. And Environmental Microbiology (1997) 63: 1362-1366). The one described in was used.
  • Plasmid p AA12 which presents ⁇ -amylase from Bacillus stearothermophilus on the cell surface, was prepared using plasmid ⁇ I ⁇ 11 as a starting material.
  • Figure 1 shows a schematic diagram of the construction. Plasmid ⁇ ⁇ ⁇ 11 was treated with Xho I to separate it into a long fragment and a short fragment.
  • a plasmid obtained by self-ligating the long fragment was cut with NotI and KpnI and blunt-ended to obtain a fragment of about 860 bp.
  • This fragment has a GAP DH promoter sequence and a gene sequence encoding 320 amino acid residues from the 3 ′ side of ⁇ -agglutin.
  • the multicopy plasmid ⁇ 34 (+3) was digested with ⁇ VuII and BamHI, blunted, and the above fragment of about 860 bp was inserted into the plasmid to obtain plasmid pUGP1. I got 2.
  • a short fragment obtained by treating plasmid p I ⁇ 11 with Xho I was used to obtain a secretion signal sequence of about 2,000 b of the yeast a-functional enzyme.
  • ⁇ -amylase derived from Bacillus ste arothermophilus Encoding the mature protein sequence I have. This fragment was introduced into the XhoI site of the plasmid pUGP12 to obtain a plasmid pAAl2 used for displaying ⁇ -amylase on the cell surface.
  • Plasmid pSAAl1 which secretes ct-amylase from Bacillus stearothermophilus, is described in the literature of the inventor Tanaka Ope Ueda et al. (Murai et al., Appl. Microbiol. Biotechnol. (1999) 51: 65-70).
  • the ⁇ -amylase gene was isolated from the chromosome-integrated plasmid pIAAA1 of the above, and this was integrated into a multicopy plasmid: UGP 3 (Takahashi et al., Appl. Microbiol. Biotechnol. (2 001) 55: 454-462).
  • Figure 2 shows a schematic diagram of the construction.
  • Plasmid pSGA11 secreting darcoamylase from Rhizopus oryzae was prepared by the method shown in FIG. Using pGAl1 as a template and a primer, 5,-ATCGGGATCCATGCMCTGTTC TTTGCCATTGAAAGTT-3 '(sequence number 3) and 5,-ATCGGTCGACTTMGCGGCAGGTGCACCAGCCTTAGCGTA-3, (sequence number PCR amplification was carried out using No. 4), followed by digestion with restriction enzymes BamHI and Sa1I to obtain a BamHI-Sa1I fragment of about 1800 bp. This fragment encodes the secretory signal sequence of dalcoamylase and the mature protein sequence of dalcoamylase.
  • the multicopy plasmid p UGP3 (Takahashi et al., Supra) was digested with restriction enzymes BamHI and Sa1I, and the above-mentioned BamHI-Sa1I fragment of about 1800 bp was added thereto. Ligation produced the plasmid pSGAl1 used to secrete glycoamylase.
  • Plasmid pBAAl which presents ⁇ -amylase derived from Streptococcus bovis 148 on the cell surface was prepared using plasmid pAA12 obtained in the above [a-2] as a starting material.
  • Figure 4 shows a schematic diagram of the plasmid pBAAl.
  • the plasmid pAAl2 was treated with XhoI and separated into a long fragment (6.9 kb) and a short fragment (1.7 kb).
  • a plasmid obtained by self-ligating the long fragment was cut with NotI and KpnI and blunt-ended to obtain a fragment of about 860 bp.
  • This fragment has a GAPDH promoter sequence and a gene sequence encoding 320 amino acid residues from the 3 ′ side of ⁇ -agglutinin.
  • the multicopy plasmid ⁇ 34 (+3) was digested with ⁇ VuII and BamHI, blunted, and the above fragment of about 860 bp was incorporated to obtain plasmid pUGP12. Was.
  • ATTTGCCATTGAAAGT-3 (SEQ ID NO: 5) and 5, -CTGCCCATGGGGTTTTAGCCCATCTT TATTATAGTTTCC-3 '(SEQ ID NO: 6)
  • a 2.2 kb DNA fragment containing the ⁇ -amylase gene derived from Streptococcus bovis 148 was obtained. This fragment was introduced into the XhoI site of the plasmid pUGP12 to obtain BAAl, a plasmid used to display ⁇ -amylase derived from Streptococcus bovis on the cell surface.
  • FIG. 5 shows a schematic diagram of the plasmid pSBAA2 that secretes a-amylase derived from Streptococcus bovis 148.
  • Plasmid p CAS 1 Using amyA as a template, primers 5'-AATAGAGCTCATGCAACTGTTCAATTTGC CATTGAAAGT-3, (SEQ ID NO: 7) and 5'-TGGCGGTACCTTATTTTAGCCCATCTTTATTA TAGTTTC-3 '(SEQ ID NO: 8) Amplified by CR and digested with restriction enzymes SacI and KpnI, a 2.2 kb DNA fragment encoding the secretory signal sequence of dalcoamylase and the mature protein sequence of dalcoamylase was obtained.
  • the multicopy-type plasmid pUGP3 (Takaha shi et al., Supra) was digested with restriction enzymes SacI and KpnI, and the above SacI- n ⁇ nI fragment was ligated therewith, thereby obtaining Streptococcus bovis-derived ⁇ .
  • a plasmid pSBAA2 used to secrete amylase was constructed. [2-7] Preparation of plasmid used to display glucoamylase derived from Rhizopus oryzae ⁇ -amylase from Streptococcus bo vis as a fusion protein with the aggregation function domain on the cell surface
  • the prepro a-factor signal sequence gene was obtained as follows. Chromosome DNA of S. cer evisiae W303-IB was extracted. Using this as a template, PCR amplification was performed using 5, -AACGGAGCTCATGAGATTTCCTTCAATTTTTACTGCAGTT-3 '(SEQ ID NO: 9) and 5, -GGGGTACCGCATGCTCTTTTATCCAAAGATACCCCTTCTTCTTT-3' (SEQ ID NO: 10) as primers. Amplify 3 &. After digestion with 1 ⁇ 113111, a SacI-KpnI fragment of a prepro-factor signal sequence of about 250 b ⁇ in length was obtained.
  • [2-7-2] Acquisition of the gene for the 5 region (aggregating functional domain) of FLO 1 The gene for the 5 'region (aggregating functional domain) of FLO 1 was obtained as follows. First, chromosomal DNA was extracted from S. cerevisiae ATCC60715. Then, using this as a template, PCR amplification was performed using 5'-AGGAGGATCCGAGGCGTGC TTACCAGCAGGCCAGAGGAAA-3 '(SEQ ID NO: 11) and 5, -GCGAGTCGACTTMGATCT GGTGATTTGTCCTGAAGATGATGATGACAAA-3' (SEQ ID NO: 12) as primers, and the amplified product was BamH.
  • the plasmid pGA11 containing the darcoamylase gene was used as a template, and 5'-CGTTGGATCCGCAAGCATTCCTAGT AGTGCTTCTGTCCAG-3, (SEQ ID NO: 13) and 5'-ATCGGGATCCAGCGGCAGGTGCACC AGCCTTAGCGTA-3 '(SEQ ID NO: 14) were used as primers.
  • the amplified product was digested with BamHI to obtain an approximately 1800 bp dalcoamylase gene BamHI fragment. This fragment encoded the mature protein sequence excluding the secretory signal sequence of dalcoamylase.
  • the ⁇ -amylase gene of Streptococcus bovis was obtained as follows. Briefly, first, plasmid pQE31 :: amyA containing the ⁇ -amylase gene was used as a template, and 5,-CGTTAGATCTGAT GAACAAGTGTCAATGAAAGATGGTACG-3 '(SEQ ID NO: 15) and 5'-ATMCTCGAGTTA TTTTAGCCCATCTTTATTATAGTTTCC- PCR amplification was performed using 3 ′ (SEQ ID NO: 16), and the amplified product was digested with Bg1II and XhoI to obtain an approximately 2000 bp ⁇ -amylase gene Bg1II-XhoI fragment. Obtained. This fragment encoded the mature protein sequence except for the secretory signal sequence of the heat amylase.
  • plasmid pUC119 was digested with SacI and Kp ⁇ I, the SacI-KpnI fragment of the prepro a-factor signal sequence obtained in [2-7-1] was inserted. Then, plasmid; UC119 ⁇ was obtained. This plasmid pUC119 ⁇ was digested with BamHI and Sa1I, and the BamHI_Sa1I fragment of the FLO1 gene obtained in [2-7-2] above was obtained. And insert p UC 1 19 a FS was obtained.
  • the plasmid was inserted into the yeast constitutive expression plasmid pWGP3 digested with, and the yeast surface display plasmid pWGaFS was obtained.
  • the monoamylase gene Bg obtained in [2-7-4] above is digested.
  • the 1II-XhoI fragment was inserted to obtain a plasmid for surface display of human amylase pWGaFSA.
  • ⁇ -amylase is expressed as a fusion protein fused to the C-terminal side of the FLOl aggregation functional domain.
  • the plasmid pWGaFSA obtained in [2-7-6] is digested with BamHI, dephosphorylated, and the dalcoamylase gene BamHI fragment obtained in [2-7-3] is digested.
  • a plasmid pWGaGF S plasmid for displaying dalcoamylase and ⁇ -amylase as a fusion protein on the cell surface was obtained. Dalcoamylase and ⁇ -amylase are expressed as fusion proteins fused to the C-terminal side of the FLOL aggregation functional domain.
  • the plasmid pWGaFS for yeast surface display obtained in [2-7-5] is digested with BamHI, dephosphorylated, and the darcoamylase gene B a obtained in [2-7-3] is obtained.
  • the mHI fragment was inserted to obtain a plasmid pWGaGFS for display on the surface of Dalcoamylase.
  • the darcoamylase is expressed as a fusion protein fused to the N-terminal side of the FLO1 aggregation functional domain.
  • Example 1 Preparation of a flocculant yeast which presents dalcoamylase derived from Rhizopus oryzae on the cell surface by means of a GPI anchor and secretes human amylase derived from Bacillus stearothermophilus.
  • Plasmids for displaying dalcoamylase from Rhizopus oryzae on the cell surface with a GPI anchor: GAl1 and a plasmid for secreting ⁇ -amylase from Bacillus stearothermophilus; SAA1 1 and Yeast Maker (Clontech Laboratories , Inc., Palo Alto, Calif.) was simultaneously introduced into yeast YF207 by the lithium acetate method.
  • SD agar medium (6.7 g / l Yeast nitrogen base w / o amino acids (Difco Laboratories)) supplemented with appropriate amino acids and bases not containing L-tryptophan or uracil, 2 % Glucose, 0.02 g / l adenine sulfate, 0.02 g / 1 L-histidine / 1 ⁇ 1, 0.03 g / l L-leucine, 0.02 g / l L-lysine).
  • the grown yeast was selected and named as YF207-pGAl1 + PSAA11.
  • Plasmid pSGA11 for secreting dalcoamylase and plasmid pAAl2 for displaying ⁇ -amylase on the cell surface by GPI anchor were simultaneously introduced into yeast YF207 in the same manner as in Example 1.
  • the obtained yeast was designated as YF20 ⁇ / v SGA11 + pAA12.
  • Plasmid pGAl1 was transferred to yeast YF207 in the same manner as in Example 1 ', except that plasmid pGAl1 for presenting darcoamylase derived from Rhizopus oryzae on the cell surface was used, and peracyl lOg / 1 was added to the selection medium.
  • the yeast thus introduced and obtained was named YF207 / pGAl1.
  • Example 1 Each 5 ml of the transformed yeast obtained in Example 1 and Comparative Examples 1 to 3 was inoculated into 100 ml of SD medium containing 1% casamino acid (manufactured by Difco Laboratories), and shaken at 30 ° C. for 48 hours. Thus, seed culture was performed.
  • each seed culture was added to 1 L of 4% YPS medium (10 g / l Og / 1 yeast extra Tato (manufactured by Dco Laboratories), 20 g / l polypeptone (manufactured by Wako Pure Chemical Industries, Ltd.), 40 g / l starch (soluble) (manufactured by Wako Pure Chemical Industries, Ltd.), 5 g / l glucose were pre-filled.
  • YPS medium 10 g / l Og / 1 yeast extra Tato (manufactured by Dco Laboratories), 20 g / l polypeptone (manufactured by Wako Pure Chemical Industries, Ltd.), 40 g / l starch (soluble) (manufactured by Wako Pure Chemical Industries, Ltd.), 5 g / l glucose were pre-filled.
  • YPS medium 10 g / l Og / 1 yeast extra Tato (manufactured by Dco Laboratories),
  • the pH of the medium was maintained at 5.0 by the addition of sodium sulfate sulfate, and the dissolved oxygen concentration (DO) was maintained at 2.0 ppm by adjusting the stirring speed. After the weight of the dried cells reached about 15 g / l, the medium was removed, and the cells were collected by centrifugation at 5000 rpm for 10 minutes.
  • the yeast strain YF207 which is a host of the yeast used, hardly grew in this medium.
  • each of the collected yeast pellets is inoculated into 1 L of 6% YPS medium (that is, containing 60 g / l starch) in a jar arm mentor, and subjected to anaerobic conditions at pH 5.0 and 30 ° C. Fermentation was carried out for about 35 hours with gentle stirring (150 rpm) underneath. Throughout the cultivation and fermentation steps, starch concentration, dry cell weight, and ethanol concentration were determined.
  • the starch concentration was measured as follows. Cells were separated from the 1.0 ml sample by centrifugation at 5000 rpm for 5 minutes, and the supernatant was diluted with distilled water and used for starch concentration measurement. From Aspergillus niger of Darco amylase solution (6100 units / m l, Sigma Chemical Co., St. Louis, M0) were diluted 100-fold with distilled water, Darco amylase solution 0. lml the diluted sample of 0. 9 ml In addition, it was incubated at 30 ° C for 30 minutes. After the reaction was stopped by boiling for 10 minutes, the glucose concentration in the solution was measured using a glucose CII Test Co. (Wako Pure Chemical Industries, Ltd.) and a spectrophotometer (U-2001, Hitachi). And converted to starch concentration.
  • Aspergillus niger of Darco amylase solution (6100 units / m l, Sigma Chemical Co., St. Louis, M0) were diluted 100-fold with
  • the ethanol concentration was measured using a gas chromatograph equipped with a flame ionization detector.
  • the measurement was performed using 24 graphs (Model GC-8; manufactured by Shimadzu Corporation).
  • the measurement conditions were as follows: column, 3.0 side x 3.30 lm of Unisole 300 0 (GL Science Inc.) packed in glass; column temperature, 210 ° C; injector / detector temperature, 270 ° C; carrier gas, nitrogen (flow rate: 25 ml / min).
  • Table 1 shows the results of alcohol fermentation by cultivation and fed-batch culture of various yeasts.
  • feed l and feed 2 indicate the amount of starch (g) added after the measurement of the starch concentration at 36 hours and 72 hours, respectively.
  • the yeast of the present invention which presents dalcoamylase on the cell surface by means of a GPI anchor and secretes ⁇ - amylase, did not differ greatly from other yeasts in the growth phase.
  • the capacity was found to be superior to other yeasts (Example 2).
  • the alcohol production of the yeast of the present invention was about 77 g / l, which means that about 40% of the added starch was converted to alcohol. This value proved to be practical, comparable to the case where glucose was used as a substrate.
  • the alcohol yield of other yeasts is 34% for yeast that presents glucoamylase and ⁇ -amylase on the cell surface using a GPI anchor, and dalcoamylase is that when ⁇ -amylase is presented on the cell surface using a GPI anchor.
  • dalcoamylase is that when ⁇ -amylase is presented on the cell surface using a GPI anchor.
  • Example 3 Preparation of flocculent yeast which presents dalcoamylase derived from Rhizopus oryzae on the cell surface with a GPI anchor and secretes Streptococcus bovis-derived human amylase
  • the plasmid pGAl1i for displaying Dalcoamylase derived from Rhizopus oryzae on the cell surface with a GPI anchor and the plasmid pSBAA2 for secreting human amylase derived from Streptococcus bovis were used in the same manner as in Example 1 to obtain yeast YF.
  • the resulting yeast was named YF207 / [pGA11, SBAA2].
  • a plasmid pGAl1 for displaying Rhizopus oryzae-derived darcoamylase on the cell surface with a GPI anchor and a plasmid pBAAl for displaying ⁇ -amylase from Streptococcus bovis with a GPI anchor on the cell surface were prepared in Examples.
  • the yeast was simultaneously introduced into yeast YF207 in the same manner as in 1, and the resulting yeast was named YF207Z [pGAl1, BAA1].
  • Plasmid pBAAl for displaying Streptococcus bovis-derived CK monoamylase on the cell surface with a GPI anchor was introduced into yeast YF207 in the same manner as in Example 1, and the obtained yeast was named YF207 / pBAA1.
  • Plasmid P SBAA2 for secreting ⁇ -amylase derived from Streptococcus bovis was introduced into yeast YF207 in the same manner as in Example 1, and the obtained yeast was named YF207 / pSBAA2.
  • Example 3 For the yeasts obtained in Example 3 and Comparative Examples 7 to 9, expression of the cell surface of dalcoamylase by the plasmid pGAl1 was confirmed by flow cytometry analysis. The ⁇ -amylase activity of secretory expression by SBAA2 was confirmed by blue starch plate.
  • YF207 / [pGA11, pBAAl] co-presenting 29 ⁇ -amylase also grew well on steamed corn starch. These two types of recombinant yeast also consumed a large amount of starch in the culture medium after culturing for 48 hours.
  • Example 5 Preparation of non-aggregating yeast that presents Dalcoamylase from Rizopus oryzae and ⁇ -amylase from Streptococcus bovis as a fusion protein with an aggregation function domain on the cell surface
  • the plasmid pWG ⁇ GFSA obtained in [2-7-7] of Reference Example 2 above was non-aggregated yeast S. by the lithium acetate method using Yeast Maker (Clontech Laboratories, Inc., Palo Alto, CA). cerevisiae MT8-1 was introduced. This was purified using SD-W agar selection medium (6.7% yeast nitrogen base w / o amino acids (Difc Laboratories), 2% glucose, 2% agar powder supplemented with appropriate amino acids and bases without L-tryptophan). ). The grown yeast was selected, and the obtained transformant was named MT8-lZpWGaGFSA (Dalcoamylase + ⁇ -amylase fusion surface display yeast).
  • the plasmid pWGaGFS for displaying the Rhizopus oryzae-derived glycoamylase obtained in [2-8] of Reference Example 2 above on the cell surface was introduced into the non-aggregating yeast MT 8-1 in the same manner as in Example 5.
  • the obtained yeast was designated as MT 8-1 / pWG aGFS (Dulcoamylase surface-displaying yeast).
  • Comparative Example 15 Preparation of flocculant yeast that presents ⁇ -amylase derived from Streptococcus bovis on the cell surface by a flocculant domain) 8234
  • 31-Plasmid pWGaFSA for displaying Streptococcus bovis-derived CK monoamylase obtained in [2-7-6] of Reference Example 2 above on the cell surface was added to non-aggregating yeast MT8 in the same manner as in Example 5.
  • the resulting yeast was named MT 8-1 / p WGaF SA ( ⁇ -amylase surface display yeast).
  • a plate assay for dalcoamylase activity was performed as follows. After streaking each transformant on a plate medium consisting of 1% yeast extract, 2% peptone, 3% soluble starch, 0.003% promocresol purple, 0.5% glucose, and 2% agar powder, streak at 30 ° C. For 2 days and then at 4 ° C for 2 days. Glucoamylase activity was detected by observing a clear halo formed around the colony. The result is shown in FIG.
  • Dalcoamylase Surface-displaying yeast MT8-1 / pWGaGFS and Darcoamylase + ⁇ -amylase fusion surface-displaying yeast ⁇ 8-1 / pWGaGFSA was found to have sufficient dalcoamylase activity.
  • yeast cells displaying ⁇ -amylase on the surface of MT8-1 / pWG and FSA showed faint mouth formation.
  • a plate assay for ⁇ -amylase activity was performed as follows. Each transformant was streaked on a plate medium consisting of 1% yeast extract, 2% peptone, 0.25% remazole starch, 2% glucose, and 2% agar powder, and then cultured at 30 ° C for 4 days. Observing a clear halo formed around the colony As a result, ⁇ -amylase activity was detected. The result is shown in FIG.
  • ⁇ -amylase surface-displaying yeast ⁇ 8-1 / pWGaFSA and glucoamylase + ⁇ -amylase fusion surface-displaying yeast MT8-lZpWGoiGFSA It can be seen that it has an ⁇ -amylase activity. Also, as can be seen from the size of the mouth, the yeast displaying the surface of the dalcoamylase + ⁇ - amylase fusion surface was higher in activity than the yeast displaying the surface of the ⁇ - amylase. This indicates that fusion expression of the two amylases is useful.
  • 200 ml of the transformed yeast obtained in Example 5 was inoculated into 100 ml of YSP medium containing 5 g / l D-glucose (10 g / l yeast extract, 20 g / l polypeptone, 20 g / l steamed corn starch).
  • the yeast cells are grown and grown at 30 ° C with shaking under aerobic conditions for 48 hours, consuming starch and producing ethanol.
  • the yeast of the present invention which presents dalcoamylase on the surface and secretes ⁇ -amylase, is a yeast which presents dalcoamylase and ⁇ -amylase on the cell surface, respectively, when grown using starch as a substrate.
  • Yeast that presents dalcoamylase on the surface and secretes glucoamylase, and yeast that presents glucoamylase to cells are not much different, but have higher alcohol fermentation ability from starch than other yeasts. Since the alcohol yield is 40%, which is comparable to alcohol fermentation from Darcos, it is useful for producing ethanol directly from starch.
  • ⁇ -amylase derived from Streptococcus bovis when used for secretion, it is possible to use uncooked starch as a carbon source. Can also produce alcohol in high yield. Therefore, it is possible to produce ethanol more efficiently without cooking raw starch.
  • dalcoamylase + ⁇ -amylase fusion surface-displaying yeast also has the ability to efficiently ferment starch with alcohol, and is therefore useful for direct ethanol production from starch.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A plasmid having been constructed so as to present glucoamylase on its surface layer and secret α-amylase is integrated into a yeast and then the yeast is grown using starch as a substrate. Thus, al alcohol can be efficiently produced by fermentation directly from the starch. This yeast is superior in alcohol fermentability to a yeast presenting glucoamylase and α-amylase on the cell surface layer, a yeast presenting α-amylase on the cell surface layer and secreting glucoamylase, and a yeast presenting glucoamylase on the surface layer. Using α-amylase originating in Streptococcus bovis, moreover, ethanol can be directly produced from uncooked starch. It is also possible to employ a yeast which presents on the cell surface layer glucoamylase and α-amylase as a fused protein with the agglutination function domain of a sugar chain-binding protein.

Description

明 細 書 デンプンからアルコールを製造する方法 技術分野  Description Method for producing alcohol from starch

本発明は、 デンプンからのエタノールの製造方法に関する。 詳しくは、 グ ルコアミラーゼを細胞表面に提示し、 かつ α—アミラーゼを分泌する酵母を 用いる、 エタノールの製造方法に関する。 あるいは、 ダルコアミラーゼおよ ぴ α—アミラーゼを融合タンパク質として細胞表層に提示する酵母を用レヽる、 エタノールの製造方法に関する。 さらに詳しくは、 上記のような酵母を用い て無蒸煮デンプンからエタノールを製造する方法に関する。 背景技術 The present invention relates to a method for producing ethanol from starch. More specifically, the present invention relates to a method for producing ethanol using yeast which presents glycoamylase on the cell surface and secretes α -amylase. Alternatively, the present invention relates to a method for producing ethanol using yeast that displays dalcoamylase and α-amylase as a fusion protein on the cell surface. More specifically, the present invention relates to a method for producing ethanol from uncooked starch using the yeast as described above. Background art

新しいエネルギー資源としてのバイオマスの利用が、 近年注目されている。 植物起源のセルロースおよびデンプン性物質は、 最も豊富に存在する利用可 能なバイオマス資源である。 特に、 デンプン資源から生産されるエタノール は、 再生可能な環境調和型エネルギー資源として注目され、 今後その需要が 増加すると予想されている。  The use of biomass as a new energy resource has attracted attention in recent years. Cellulose and starchy substances of plant origin are the most abundant and available biomass resources. In particular, ethanol produced from starch resources is attracting attention as a renewable environmentally-friendly energy resource, and the demand for it is expected to increase in the future.

現在の発酵法によるデンプンからのェタノール生産は、 デンプンの蒸煮後、 アミラーゼを分泌する麹菌などでの処理によるデンプン質の糖化、 およぴ酵 母によって発酵するという 2段階の工程で行われている。 これは、 酵母はァ ミラーゼ類を有しないため、 デンプンを分解して糖化することができないか らである。  Ethanol production from starch by the current fermentation method is carried out in two stages: starch is steamed, starch is saccharified by treatment with koji mold that secretes amylase, and fermentation is performed by fermentation. . This is because yeast does not have amylases and therefore cannot degrade and saccharify starch.

酵母に糖化型のアミラーゼ (ダルコアミラーゼ) をコードする遺伝子を導 入して糖化型のアミラーゼを分泌させるようにし、 この酵母をデンプンを唯 —の炭素源として生育させ、 アルコール発酵を試みた例がある (Nakamuraら、 Biotechnol. Bioeng. , 53 : 21 - 25 (1997) ) 。 しかし、 酵母の生育が良好では なく、 エタノール生産量も低く、 実用的ではなかった。 さらに、 ダルコアミ ラーゼを酵母の細胞表層に固定化し、 この酵母をデンプンを唯一の炭素源と して生育させ、 エタノールを生産する試みがなされ、 エタノールの生産量を 増加させること成功している (植田ら、 Appl. Environ. Microbiol. , 63: 13 62-1366 (1997) ) が、 未だ実用化されるに至っていない。 発明の開示 An example of introducing a gene encoding a saccharified amylase (Dulcoamylase) into yeast to secrete saccharified amylase, growing this yeast using starch as the sole carbon source, and attempting alcohol fermentation. Yes (Nakamura et al. Biotechnol. Bioeng., 53: 21-25 (1997)). However, the growth of the yeast was not good, and the ethanol production was low, making it impractical. Furthermore, an attempt was made to immobilize dalcoamylase on the cell surface of yeast, grow this yeast using starch as the sole carbon source, and produce ethanol, and succeeded in increasing ethanol production (Ueda Appl. Environ. Microbiol., 63: 13 62-1366 (1997)) has not yet been put to practical use. Disclosure of the invention

そこで、 本発明は、 デンプンから直接的に、 より高い効率でエタノールを 生産できる酵母の構築おょぴそれを利用してエタノールを製造する方法を提 供することを目的とする。  Therefore, an object of the present invention is to construct a yeast capable of producing ethanol directly and more efficiently from starch, and to provide a method for producing ethanol using the yeast.

本発明者らは、 デンプンからの効率的なェタノールの生産について種々検 討した結果、 ダルコアミラーゼを細胞表面に提示し、 かつ α—アミラーゼを 分泌または細胞表層に提示するように酵母を形質転換することによって、 ェ タノール生産性が顕著に向上することを見出し、 本発明を完成するに至った。 したがって、 本発明は、 ダルコアミラーゼを細胞表層に提示し、 かつ α— ァミラーゼを分泌する酵母を提供する。 As a result of various studies on efficient production of ethanol from starch, the present inventors transformed yeast to display dalcoamylase on the cell surface and to secrete or display α -amylase on the cell surface. As a result, it was found that ethanol productivity was significantly improved, and the present invention was completed. Accordingly, the present invention provides a yeast which displays dalcoamylase on the cell surface and secretes α-amylase.

好適な実施態様では、 上記ダルコアミラーゼは、 G P Iアンカーを介して 提示されている。  In a preferred embodiment, the dalcoamylase is presented via a GPI anchor.

好適な実施態様では、 上記ダルコアミラーゼは、 G P Iアンカ一付着認識 シグナル配列を有さない糖鎖結合タンパク質ドメインとの融合タンパク質と して提示されている。  In a preferred embodiment, the dalcoamylase is presented as a fusion protein with a sugar chain binding protein domain that does not have a GP I anchor attachment recognition signal sequence.

本発明はまた、 ダルコアミラーゼおよび α—ァミラーゼ融合タンパク質を、 The present invention also provides a darcoamylase and α-amylase fusion protein,

G Ρ Iアンカー付着認識シグナル配列を有さない糖鎖結合タンパク質ドメィ ンとの融合タンパク質として細胞表層に提示する酵母であって、 該ドメイン の一端に該ダルコアミラーゼが融合され、 そして他端に該ひ一アミラーゼが 融合されている、 酵母を提供する。 A yeast which is displayed on a cell surface as a fusion protein with a sugar chain binding protein domain having no GΡI anchor attachment recognition signal sequence, wherein the dalcoamylase is fused to one end of the domain, and the other end is the yeast. Hi-amylase Provide yeast that has been fused.

好適な実施態様では、 上記糖鎖結合タンパク質ドメィンは、 少なくとも G P Iアンカータンパク質の凝集機能ドメインを含む部分である。  In a preferred embodiment, the sugar chain binding protein domain is a portion containing at least an aggregation functional domain of a GP I anchor protein.

より好適な実施態様では、 上記 GP Iアンカータンパク質は、 凝集タンパ ク質である。  In a more preferred embodiment, the GPI anchor protein is an aggregated protein.

さらに好適な実施態様では、 上記凝集タンパク質は、 FL01、 FL02、 FL04、 FL05、 FLO 9, FLO 10, および FLO 11からなる群 より選択されるタンパク質である。  In a further preferred embodiment, the aggregated protein is a protein selected from the group consisting of FL01, FL02, FL04, FL05, FLO9, FLO10, and FLO11.

他の好適な実施態様では、 上記 α—アミラーゼは Streptococcus bovis 14 8由来である。  In another preferred embodiment, the α-amylase is from Streptococcus bovis 148.

本発明はまた、 上記酵母を、 デンプンを含む培地で培養する工程を含む、 アルコールの製造方法を提供する。  The present invention also provides a method for producing alcohol, comprising a step of culturing the yeast in a medium containing starch.

好適な実施態様では、 上記デンプンは無蒸煮である。 図面の簡単な説明  In a preferred embodiment, the starch is uncooked. BRIEF DESCRIPTION OF THE FIGURES

図 1は、 α—アミラーゼを GP Iアンカーにより細胞表層に提示するプラ スミド pAAl 2の構築を示す模式図である。  FIG. 1 is a schematic diagram showing the construction of a plasmid pAAl2 that presents α-amylase on the cell surface by a GPI anchor.

図 2は、 α—アミラーゼを分泌するプラスミド p SAA1 1の構築を示す 模式図である。  FIG. 2 is a schematic diagram showing the construction of plasmid pSAA11 that secretes α-amylase.

図 3は、 ダルコアミラーゼを分泌するプラスミ ド p SGAl 1の構築を示 す模式図である。  FIG. 3 is a schematic diagram showing the construction of plasmid pSGAl1, which secretes dalcoamylase.

図 4は、 プラスミド BAA1の模式図である。  FIG. 4 is a schematic diagram of the plasmid BAA1.

図 5は、 プラスミド p SB AA 2の模式図である。  FIG. 5 is a schematic diagram of the plasmid pSBAA2.

図 6は、 各種組換え酵母細胞を好気的条件下で培養した場合の、 デンプン 濃度およぴ細胞密度の経時変化を示すダラフである。  FIG. 6 is a graph showing changes over time in starch concentration and cell density when various recombinant yeast cells are cultured under aerobic conditions.

図 7は、 無蒸煮コーンスターチ培地を用いてアルコール発酵した場合の、 培地中のデンプン濃度おょぴェタノール濃度の経時変化を示すグラフである。 図 8は、 種々の濃度の無蒸煮コーンスターチを用いた場合の、 培地中のデ ンプン濃度およびエタノール濃度の経時変化を示すグラフである。 Figure 7 shows the results of alcohol fermentation using uncooked corn starch medium. It is a graph which shows a time-dependent change of the starch density | concentration in a culture medium, and a concentration of ethanol. FIG. 8 is a graph showing the time-dependent changes in the starch concentration and the ethanol concentration in the medium when various concentrations of non-steamed corn starch are used.

図 9は、 種々の濃度の酵母 Y F 2 0 7 / [ p G A l 1 , p S B AA 2 ] を 用いた場合の、 培地中のデンプン濃度およびエタノール濃度の経時変化を示 すグラフである。  FIG. 9 is a graph showing the time-dependent changes in the starch concentration and the ethanol concentration in the medium when various concentrations of yeast YF207 / [pGA11, pSBAA2] were used.

図 1 0は、 グ コアミラーゼ活"生についてのプレートアツセィの結果を示 すプレートの写真である。  FIG. 10 is a plate photograph showing the results of a plate assay on glucoamylase activity.

図 1 1は、 α—アミラーゼ活性についてのプレートアツセィの結果を示す プレートの写真である。 発明を実施するための最良の形態  FIG. 11 is a photograph of a plate showing the results of plate assay for α-amylase activity. BEST MODE FOR CARRYING OUT THE INVENTION

本明細書において、 ダルコアミラーゼとは、 デンプンの非還元末端からグ ルコース単位を切り離していくェキソ型の加水分解酵素をいう。 このような 活性を有していれば、 その起源は限定されず、 例えば Rhizopusおよび Asperg illusなどのカビ由来のダルコアミラーゼが用いられる。 例えば、 植田ら (A ppl. Environ. Microbiol. 63 : 1362 - 1366 (1997) ) に記載のように、 Rhizopu s oryzae由来のダルコアミラーゼが好適に用いられる。  As used herein, dalcoamylase refers to an exo-type hydrolase that separates a glucose unit from the non-reducing end of starch. The origin is not limited as long as it has such an activity. For example, darcoamylase derived from molds such as Rhizopus and Aspergillus is used. For example, as described in Ueda et al. (Appl. Environ. Microbiol. 63: 1362-1366 (1997)), darcoamylase derived from Rhizopu s oryzae is preferably used.

本発明において、 α—アミラーゼとは、 デンプンの α 1 , 4—ダルコシド 結合を加水分解するエンド型の酵素をいう。 この活性を有していればその起 源は限定されず、 例えば、 動物 (唾液、 脖臓など) 、 植物 (麦芽など) 、 お ょぴ微生物由来の α—アミラーゼが用いられる。 本発明においては、 微生物 由来の αアミラーゼ力 s好適【こ用レヽられ、 例えほ、、 Bacillus stearothermophi lus、 Streptococcus bovisなどに由来するものが挙げられる。 後述するよう に、 特に、 無蒸煮デンプンを炭素源とする場合には、 Streptococcus bovis 由来の α—アミラーゼが好ましい。 本発明の第一の酵母は、 ダルコアミラーゼを細胞表層に提示し、 かつ α— ァミラーゼを分泌するように形質転換された酵母である。 このような酵母は、 グルコアミラーゼを細胞表層に提示するように組換えられた D Ν Αと、 α— 了ミラーゼを分泌するように組換えられた D Ν Αとを酵母に導入することに より、 得られる。 In the present invention, α-amylase refers to an endo-type enzyme that hydrolyzes α1,4-darcoside bonds of starch. The source of the activity is not limited as long as it has this activity. For example, α-amylase derived from animals (such as saliva and kidney), plants (such as malt), and microorganisms is used. In the present invention, alpha-amylase force derived from a microorganism s preferred [this for Rere is, for example ho ,, Bacillus stearothermophi lus, include those such as from Streptococcus bovis. As described later, α-amylase derived from Streptococcus bovis is particularly preferred when uncooked starch is used as a carbon source. The first yeast of the present invention is yeast transformed to present dalcoamylase on the cell surface and secrete α-amylase. Such a yeast can be obtained by introducing into a yeast D Ν 組 換 え recombined to display glucoamylase on the cell surface and D Ν 組 換 え recombined to secrete α-amylase. , can get.

また、 本発明の第二の酵母は、 ダルコアミラーゼおよび α—アミラーゼを、 糖鎖結合タンパク質ドメインとの融合タンパク質として細胞表層に提示する ように形質転換された酵母である。 このような酵母は、 ダルコアミラーゼ、 α—アミラーゼ、 およぴ糖鎖結合タンパク質ドメインを 1つの融合タンパク 質として細胞表層に提示するように組換えられた DN Αを酵母に導入するこ とによって得られる。  The second yeast of the present invention is a yeast transformed to display dalcoamylase and α-amylase as a fusion protein with a sugar chain binding protein domain on a cell surface. Such yeasts can be obtained by introducing into the yeast a recombinant DNA that displays the darcoamylase, α-amylase, and carbohydrate-binding protein domains as a single fusion protein on the cell surface. Can be

まず、 細胞表層に酵素を提示する一般的な方法について説明する。 細胞表 層に酵素を提示する方法には、 (a) 細胞表層局在タンパク質の GP Iアン カーを介して酵素を細胞表層に提示する方法、 および (b) 細胞表層局在タ ンパク質の糖鎖結合タンパク質ドメインを介して酵素を細胞表層に提示する 方法がある。 1種の酵素を細胞表層に提示する場合は、 (a) および (b) のいずれの方法を用いてもよい。 なお、 2種の酵素を細胞表層に提示する場 合は、 (b) の方法によって融合タンパク質と発現することが好ましい。 用いられ得る細胞表層局在タンパク質としては、 酵母の性凝集タンパク質 である α—または a—ァグルチュン、 FLOタンパク質 (例えば、 FL01、 FLO2、 FL04、 FL05、 FL09、 FLO 10, および FLOl 1) 、 アルカリホスファターゼなどが挙げられる。  First, a general method for presenting an enzyme on the cell surface will be described. The method of presenting the enzyme on the cell surface includes: (a) a method of presenting the enzyme to the cell surface via a GPI anchor of a cell surface-localized protein; and (b) a method of displaying the sugar on the cell surface-localized protein. There is a method in which an enzyme is displayed on the cell surface through a chain binding protein domain. When one type of enzyme is displayed on the cell surface, any of the methods (a) and (b) may be used. When two types of enzymes are displayed on the cell surface, it is preferable to express the fusion protein by the method (b). Cell surface localization proteins that can be used include yeast sex aggregation proteins α- or a-agglutune, FLO proteins (eg, FL01, FLO2, FL04, FL05, FL09, FLO10, and FLOl 1), alkaline phosphatase And the like.

(a) GP Iアンカーを利用する方法  (a) How to use GPI anchor

GP Iアンカーにより細胞表層に局在するタンパク質をコードする遺伝子 は、 N末端側から順に、 分泌シグナル配列、 細胞表層局在タンパク質 (糖鎖 結合タンパク質ドメイン) 、 および G P Iアンカ一付着認識シグナル配列を それぞれコードする遺伝子を有している。 細胞内でこの遺伝子から発現され た細胞表層局在タンパク質 (糖鎖結合タンパク質) は、 分泌シグナルにより 細胞膜外へ導かれ、 その際、 GP Iアンカー付着認識シグナル配列は、 選択 的に切断された C末端部分を介して細胞膜の GP Iアンカーと結合して細胞 膜に固定される。 その後、 P I— PLCにより、 GP Iアンカーの根元部が 切断され、 細胞壁に組み込まれて細胞表層に固定され、 細胞表層に提示され る。 Genes encoding proteins localized on the cell surface by the GPI anchor include, in order from the N-terminus, a secretory signal sequence, a cell surface localized protein (sugar chain binding protein domain), and a GPI anchor attachment recognition signal sequence. Each has an encoding gene. The cell surface localization protein (sugar chain binding protein) expressed from this gene in the cell is guided out of the cell membrane by a secretory signal, and the GPI anchor attachment recognition signal sequence is selectively cleaved. It is fixed to the cell membrane by binding to the GPI anchor of the cell membrane via the terminal part. Thereafter, the root of the GPI anchor is cut off by PI-PLC, incorporated into the cell wall, fixed to the cell surface, and presented to the cell surface.

ここで、 GP Iアンカーとは、 グリコシルホスファチジルイノシトール (GP I ) と呼ばれるエタノールアミンリン酸ー 6マンノース α 1— 2マン ノース 1 - 6マンノース a 1一 4ダルコサミソ a 1一 6イノシトールリン 脂質を基本構造とする糖脂質をいい、 P I— PLCとは、 ホスファチジルイ ノシトール依存性ホスホリパーゼ Cをいう。  Here, the GPI anchor refers to a glycosylphosphatidylinositol (GPI) ethanolamine phosphate-6 mannose α 1-2 mannose 1-6 mannose a 1-4 darcosamiso a 16 inositol phospholipid basic structure PI-PLC refers to phosphatidylinositol-dependent phospholipase C.

G P Iアンカ一付着認識シグナル配列とは、 G P Iアンカ一が細胞表層局 在タンパク質と結合する際に認識される配列であり、 通常、 細胞表層局在タ ンパク質の C末端あるいはその近傍に位置する。 GP Iアンカー付着シグナ ル配列としては、 例えば酵母の ァグルチュンの C末端部分の配列が好適 に用いられる。 上記 α—ァグルチェンの C末端から 3 20アミノ酸の配列の C末端側には、 GP Iアンカー付着認識シグナル配列が含まれるので、 上記 方法に使用する遺伝子としては、 この C末端から 3 20アミノ酸の配列をコ ードする DNA配列が特に有用である。  The GPI anchor attachment recognition signal sequence is a sequence that is recognized when the GPI anchor binds to a cell surface localization protein, and is usually located at or near the C-terminus of a cell surface localization protein. As the GPI anchor attachment signal sequence, for example, the sequence of the C-terminal part of yeast agglutin is preferably used. On the C-terminal side of the sequence of C-terminal 320 amino acids from the C-terminal of the α-agglutene, a GPI anchor attachment recognition signal sequence is included. DNA sequences encoding are particularly useful.

従って、 例えば、 分泌シグナル配列をコードする DN Α—細胞表層局在タ ンパク質をコードする構造遺伝子一 GP Iアンカー付着認識シグナルをコー ドする DN A配列を有する配列において、 この細胞表層局在タンパク質をコ 一ドする構造遺伝子の全部または一部の配列を、 目的とする酵素の構造遺伝 子の配列で置換することにより、 GP Iアンカーを介して目的の酵素を細胞 表層に提示する組換え D N Aが得られる。 細胞表層局在タンパク質がひーァ T/JP02/08234 Therefore, for example, in the sequence having a DNA sequence encoding a secretion signal sequence and a DNA sequence encoding a GPI anchor attachment recognition signal, the structural gene encoding a cell surface localized protein, the cell surface localized protein Recombinant DNA that displays the target enzyme on the cell surface via a GPI anchor by replacing the sequence of all or part of the structural gene encoding the target enzyme with the sequence of the structural gene of the target enzyme Is obtained. Cell surface localization protein T / JP02 / 08234

7 グルチニンである場合、 上記 α—ァグルチニンの C末端から 3 2 0アミノ酸 の配列をコードする配列を残すように、 目的の酵素遺伝子を導入することが 好ましい。 In the case of 7-glutinin, it is preferable to introduce a target enzyme gene so as to leave a sequence encoding a sequence of 320 amino acids from the C-terminal of the α -agglutinin.

この目的とする酵素の構造遺伝子として、 グルコアミラーゼ遺伝子を用い ると、 G P Iアンカーを介して細胞表層にダルコアミラーゼを提示する組換 え D NAが得られる。  When a glucoamylase gene is used as the structural gene of the enzyme of interest, a recombinant DNA that presents dalcoamylase on the cell surface via a GPI anchor can be obtained.

( b ) 糖鎖結合タンパク質ドメインを利用する方法  (b) Method using a sugar chain binding protein domain

細胞表層局在タンパク質が糖鎖結合タンパク質である場合、 その糖鎖結合 タンパク質ドメインは、 複数の糖鎖を有し、 この糖鎖が細胞壁中の糖鎖と相 互作用または絡み合うことによって、 細胞表層に留まることが可能である。 例えば、 レクチン、 レクチン様タンパク質などの糖鎖結合部位などが挙げら れる。 代表的には、 G P Iアンカータンパク質の凝集機能ドメインが挙げら れる。 G P Iアンカータンパク質の凝集機能ドメインとは、 G P Iアンカリ ングドメインよりも N末端側にあり、 複数の糖鎖を有し、 凝集に関与してい ると考えられているドメインをいう。  When the cell surface localized protein is a sugar chain-binding protein, the sugar chain-binding protein domain has a plurality of sugar chains, and the sugar chains interact with or are entangled with the sugar chains in the cell wall. It is possible to stay. For example, a sugar chain binding site of lectin, lectin-like protein and the like can be mentioned. A typical example is the aggregation functional domain of a GPI anchor protein. The aggregation functional domain of the GPI anchor protein refers to a domain that is located on the N-terminal side of the GPI anchoring domain, has a plurality of sugar chains, and is considered to be involved in aggregation.

この細胞表層局在タンパク質 (凝集機能ドメイン) と目的の酵素とを結合 することにより、 細胞表層に酵素が提示される。 目的の酵素の種類により、 細胞表層局在タンパク質 (凝集機能ドメイン) の (1 ) N末端側に酵素を結 合させる、 (2 ) C末端側に酵素を結合させる、 および (3 ) N末端側およ ぴ C末端側の両方に、 同一または異なる酵素を結合させることができる。  The enzyme is displayed on the cell surface by binding the cell surface localized protein (aggregation function domain) with the target enzyme. Depending on the type of the target enzyme, (1) the enzyme is bound to the N-terminal side of the cell surface localized protein (aggregation functional domain), (2) the enzyme is bound to the C-terminal side, and (3) the N-terminal side. The same or different enzymes can be bound to both the C-terminal side and the C-terminal side.

従って、 例えば、  So, for example,

( 1 ) 分泌シグナル配列をコードする D NA—目的とする酵素の構造遺伝子 一細胞表層局在タンパク質 (凝集機能ドメイン) をコードする構造遺伝子、 (1) DNA encoding a secretory signal sequence—structural gene of the enzyme of interest Structural gene encoding a single cell surface localization protein (aggregation function domain)

( 2 ) 分泌シグナル配列をコードする D N A—細胞表層局在タンパク質 (凝 集機能ドメイン) をコードする構造遺伝子一目的とする酵素の構造遺伝子、(2) DNA encoding a secretory signal sequence—a structural gene encoding a cell surface localization protein (aggregation function domain) —a structural gene of an enzyme of interest;

( 3 ) 分泌シグナル配列をコードする D NA—目的とする酵素の構造遺伝子 一細胞表層局在タンパク質 (凝集機能ドメイン) をコードする構造遺伝子一 目的とする他の酵素の構造遺伝子、 などの D N A配列を作成することにより、 細胞表層に目的の酵素を提示する組換え D N Aが得られる。 凝集機能ドメイ ンを利用する場合、 G P Iアンカーは細胞表層の提示には関与しないので、 組換え D NA中に、 G P Iアンカー付着認識シグナル配列をコードする D N A配列は、 存在してもよいし、 存在しなくてもよい。 (3) DNA encoding secretory signal sequence—Structural gene of target enzyme Structural gene coding for one cell surface localization protein (aggregation function domain) 1 Structural gene of another enzyme of interest, etc. can get. When using an aggregation domain, the GPI anchor is not involved in the display of the cell surface, so the DNA sequence encoding the GPI anchor attachment recognition signal sequence may or may not be present in the recombinant DNA. You don't have to.

この目的とする酵素の構造遺伝子として、 ダルコアミラーゼ遺伝子を用い ると、 糖鎖結合タンパク質ドメインを利用して、 細胞表層にダルコアミラー ゼを提示する組換え D N Aが得られる。 あるいは、 糖鎖結合タンパク質ドメ インの N末端および C末端に、 それぞれダルコアミラーゼ構造遺伝子と α— アミラーゼ構造遺伝子とを有する組換え D N Αが得られ、 融合タンパク質と して両酵素を細胞表層に発現することもできる。  When the dalcoamylase gene is used as the structural gene of the desired enzyme, a recombinant DNA that displays dalcoamylase on the cell surface using the sugar chain binding protein domain can be obtained. Alternatively, recombinant DNΑ having a dalcoamylase structural gene and an α-amylase structural gene at the N-terminal and C-terminal of the sugar chain-binding protein domain, respectively, were obtained, and both enzymes were expressed as fusion proteins on the cell surface. You can also.

上記組換え D N Aに用いられる分泌シグナル配列は、 細胞表層局在タンパ ク質の分泌シグナル配列を用いてもよいし、 発現した酵素を細胞外へ導くこ とができる他の分泌シグナル配列を用いてもよい。 例えば、 ダルコアミラー ゼの分泌シグナル配列、 酵母の α—または a—ァグルチュンの分泌シグナル 配列、 リパーゼの分泌シグナル配列が好適に用いられる。 酵素活性に影響を 及ぼさないのであれば、 細胞表層提示後に分泌シグナル配列およびプロ配列 の一部または全部が N末端に残ってもよい。  As the secretory signal sequence used in the above-mentioned recombinant DNA, a secretory signal sequence of a protein localized on the cell surface may be used, or another secretory signal sequence capable of directing the expressed enzyme to the outside of the cell may be used. Is also good. For example, a secretory signal sequence for dalcoamylase, a secretory signal sequence for yeast α- or a-agglutin, and a secretory signal sequence for lipase are preferably used. If the enzyme activity is not affected, part or all of the secretory signal sequence and prosequence may remain at the N-terminus after cell surface display.

次に、 酵母にアミラーゼ類 (ダルコアミラーゼ、 α—アミラーゼなど) を 分泌させる方法は、 当業者には周知である。 上記分泌シグナル配列をコード する D NAに、 ダルコアミラーゼ、 α—アミラーゼなどの目的の酵素の構造 遺伝子を連結した組換え D N Αを作成し、 酵母に導入すればよい。 Next, methods for allowing yeast to secrete amylases (such as dalcoamylase and α-amylase) are well known to those skilled in the art. A recombinant DN DN in which a structural gene of a target enzyme such as dalcoamylase or α -amylase is linked to DNA encoding the above-mentioned secretory signal sequence may be introduced into yeast.

上記の各種配列を含む D N Aの合成およぴ結合は、 当業者が通常用レ、得る 技術で行われ得る。 例えば、 分泌シグナル配列とダルコアミラーゼあるいは ひ一アミラーゼの構造遺伝子との結合は、 部位特異的突然変異法を用いて行 うことができる。 この方法を用いることにより、 正確な分泌シグナル配列の 切断おょぴ活性なダルコアミラーゼあるいは 一アミラーゼの発現が可能で ある。 The synthesis and binding of DNAs containing the above-described various sequences can be performed by those skilled in the art using conventional techniques. For example, binding of the secretory signal sequence to the structural gene of dalcoamylase or human amylase is performed using site-directed mutagenesis. I can. By using this method, accurate secretory signal sequence cleavage and expression of active dalcoamylase or monoamylase are possible.

上記の目的とする配列 (組換え DNA) は、 好ましくは、 ベクターに組み 込まれる。 DNAの取得を容易にする点からは、 大腸菌とのシャトルベクタ 一であることが好ましく、 例えば、 酵母の 2 mプラスミ ドの複製起点(Or i)と ColElの複製起点とを有し、 さらに酵母選択マーカー (例えば、 薬剤耐 性遺伝子、 TRP、 LEU2など) および大腸菌の選択マーカー (薬剤耐性遺伝子 など) を有することがさらに好ましい。  The above sequence of interest (recombinant DNA) is preferably incorporated into a vector. From the viewpoint of facilitating DNA acquisition, a shuttle vector with Escherichia coli is preferable. For example, it has a replication origin (Or i) of 2 m plasmid of yeast and a replication origin of ColEl, and further has a yeast replication origin. More preferably, it has a selection marker (eg, drug resistance gene, TRP, LEU2, etc.) and an E. coli selection marker (eg, drug resistance gene).

ダルコアミラーゼあるいは α—アミラーゼ構造遺伝子を発現させるために、 この遺伝子の発現を調節するオペレーター、 プロモーター、 ターミネータ一、 ェンハンサ一などのいわゆる調節配列を含んでいることが望ましい。 例えば、 GAPDH (グリセルアルデヒド 3, 一リン酸デヒドロゲ "一ゼ) プロモー ターと GAP DHターミネータ一とを含むプラスミド p YGA2270また は pYE 22m、 あるいは UPR— I CL (イソクェン酸リアーゼ上流領 域) 配列と Te r m- I CL (イソクェン酸リアーゼのターミネーター領 域) 配列とを含むプラスミド pWI 3が挙げられる。  In order to express the dalcoamylase or α-amylase structural gene, it is desirable to include so-called regulatory sequences such as an operator, a promoter, a terminator, and an enhancer that regulate the expression of this gene. For example, the plasmid pYGA2270 or pYE 22m containing the GAPDH (glyceraldehyde 3, monophosphate dehydrogenase) promoter and the GAPDH terminator, or the UPR-ICL (isoquenate lyase upstream region) sequence And a plasmid pWI3 containing a Term-ICL (terminator region of isocitrate lyase) sequence.

酵母の細胞表層に酵素を提示する場合、 最も好適には、 プラスミド pYG A2270または p YE 22 mの G A P DHプロモーターと G A P DHター ミネ一ターの配列の間に、 分泌シグナル配列をコードする DNAと、 ダルコ アミラーゼまたは α—アミラーゼの構造遺伝子配列を有する酉己列と、 α—ァ グルチニンの C末端から 320アミノ酸をコードする配列とを結合した配列 を挿入すれば、 酵母に導入するためのベタターが製造される。  When presenting the enzyme on the cell surface of yeast, most preferably, a DNA encoding a secretory signal sequence between the sequence of the GAP DH promoter and the GAP DH terminator of the plasmid pYG A2270 or p YE 22 m, By inserting a sequence that combines the sequence of the darco amylase or α-amylase structural gene and the sequence encoding 320 amino acids from the C-terminus of α-agglutinin, a binder for introduction into yeast can be produced. Is done.

ベクターは、 マルチコピー型および染色体組込み型がある。 どの型のベタ ターにどの遺伝子を組込むかは、 当業者が適宜決定すればよい。 細胞表層に 提示される酵素と分泌される酵素とは、 同一のベクターに組込まれてもよく、 P T/JP02/08234 Vectors are available in multicopy and chromosomal integration types. Which type of vector is to be incorporated into which gene may be appropriately determined by those skilled in the art. The enzyme displayed on the cell surface and the secreted enzyme may be incorporated in the same vector, PT / JP02 / 08234

10 それぞれ異なるベクターに組込まれてもよい。  10 Each may be integrated into a different vector.

宿主の酵母としては、 糖を資化してアルコール発酵能を有する酵母であれ ば、 どのような酵母でもよレ、。 非凝集性および凝集性の酵母が用いられる。 凝集性の酵母が、 反応後の分離が簡単である点で、 あるいは簡単に固定でき るため連続反応を行い得る点で好ましい。  As the yeast of the host, any yeast can be used as long as it can utilize sugar to have alcohol fermentation ability. Non-aggregating and flocculating yeasts are used. Cohesive yeasts are preferred because they can be separated easily after the reaction, or because they can be fixed easily and can be subjected to a continuous reaction.

非凝集性の酵母としては、 特に制限はないが、 例えば、 Saccharomyces ce revisiae MT 8— 1などが挙げられる。  The non-aggregating yeast is not particularly limited, and examples thereof include Saccharomyces ce revisiae MT8-1.

凝集十生の酵母としては、 Saccharomyces diastaticus ATCC60715、 同 ATCC6 0712、 Saccharomyces cerevisiae IF01953、 同 CG1945、 同 HF7Cなどが挙げら れる。 また、 新たな凝集性酵母を構築してもよい。 例えば、 後述の実施例の 「実験材料の調製」 に示すように、 M. D. Roseら (Methods in Yeast Genet i cs, 1990, Cold Spring Harbor Laboratory Press, Cold Spring Haroor, N Y) の方法に従って、 凝集性酵母 ATCCS0712と非凝集性酵母 W303 - IBとの接合 による二倍体から、 凝集性酵母 Y F 2 0 7およびこれと同等の性質を有する 酵母を得ることができる。 本発明者らが取得した凝集性酵母 Y F 2 0 7株は、 プラスミドの保持安定性に優れ、 さらに発酵能が非常に高い。 従って、 ダル コアミラーゼを細胞表層に提示しかつ α—アミラーゼを分泌するように組換 えられた凝集性酵母 Y F 2 0 7株を用いた場合は、 エタノールの生産性は非 常に高くなる。  Examples of the yeast of flocculation are Saccharomyces diastaticus ATCC60715 and ATCC60712, Saccharomyces cerevisiae IF01953, CG1945 and HF7C. Further, a new flocculant yeast may be constructed. For example, as shown in “Preparation of Experimental Materials” in Examples below, flocculent yeast was produced according to the method of MD Rose et al. (Methods in Yeast Genetics, 1990, Cold Spring Harbor Laboratory Press, Cold Spring Haroor, NY). From the diploid obtained by conjugation of ATCCS0712 with the non-aggregating yeast W303-IB, it is possible to obtain an aggregating yeast YF207 and a yeast having properties equivalent thereto. The flocculent yeast strain YF207 obtained by the present inventors has excellent plasmid retention stability, and has very high fermentation ability. Therefore, when the flocculent yeast strain YF207 which is dal coamylase displayed on the cell surface and is recombinantly secreted to secrete α-amylase is used, the productivity of ethanol is extremely high.

本発明のグルコアミラーゼを細胞表層に提示しかつ α—アミラーゼを分泌 する酵母、 あるいはダルコアミラーゼおよび α—アミラーゼを融合タンパク 質として細胞表層に提示する酵母 (以下、 これらをまとめて本発明の酵母と いう) は、 上記それぞれの酵素をコードする D N Aを有する組換え D NA (ベクター) を、 酵母に同時にまたは別々に導入することにより得られる。 D N Αの導入の方法には、 形質転換、 形質導入、 トランスフエクシヨン、 コ トランスフエクシヨン、 エレクト口ポレーシヨンなどの方法があり、 具体的 には、 酢酸リチウムを用いる形質転換方法、 プロトプラスト法などがある。 組換え D NA (ベクター) が導入された酵母は、 選択マーカー (例えば TR P、 URA) で選択される。 ダルコアミラーゼまたは α—アミラーゼが細胞表層 に提示されていることは、 細胞を洗浄した後に、 例えば抗グルコアミラーゼ 抗体または抗ひ一ァミラーゼ抗体と FITC標識抗体とを用いる免疫抗体法によ つて確認し得る。 また、 α—アミラーゼが分泌されていることも、 細胞を除 去した培養液について、 例えば抗 ーァミラーゼ抗体を用いる免疫抗体法に よって確認し得る。 A yeast which presents the glucoamylase of the present invention to the cell surface and secretes α-amylase, or a yeast which presents dalcoamylase and α-amylase to the cell surface as a fusion protein (hereinafter referred to as the yeast of the present invention and ) Can be obtained by simultaneously or separately introducing recombinant DNA (vector) having DNAs encoding the above enzymes into yeast. Methods for introducing DNΑ include transformation, transduction, transfection, co-transfection, and electoral poration. Examples include a transformation method using lithium acetate and a protoplast method. Yeast into which the recombinant DNA (vector) has been introduced is selected with a selectable marker (eg, TRP, URA). The presence of dalcoamylase or α-amylase on the cell surface can be confirmed after washing the cells, for example, by an immunoantibody method using an anti-glucoamylase antibody or an anti-amylase antibody and a FITC-labeled antibody. . The secretion of α-amylase can also be confirmed in a culture solution from which cells have been removed, for example, by an immunoantibody method using an anti-amylase antibody.

本発明の酵母は、 担体に固定ィ匕されていてもよい。 固定されていると、 繰 り返し回分努酵または連続発酵における使用に便利である。 酵母の固定化は、 当業者が通常酵母に対して用いる方法が、 適用される。 固定化された酵母は、 担体に付着した状態で、 浮遊状態で培養されるカ カラムなどに充填されて、 いわゆるバイオリアクターとして用いることもできる。 連続的にあるいは回 分 (バッチ)で繰り返し培養おょぴ発酵させた場合でも、 活性が低下したあ るいは死滅した酵母が脱離していくので、 酵母としての活性が低下すること はなく、 有効に利用することができる。  The yeast of the present invention may be immobilized on a carrier. When fixed, it is convenient for use in repeated batch or continuous fermentations. For the immobilization of yeast, a method usually used for yeast by those skilled in the art is applied. The immobilized yeast can be used as a so-called bioreactor by being attached to a carrier and filled in a column that is cultured in a suspended state. Even if the fermentation is repeated continuously or in batches (batch), the activity of the yeast decreases or the dead yeast is eliminated, so that the yeast activity does not decrease and the yeast is effective. Can be used for

以下、 本発明の酵母をデンプン存在下で発酵させて、 エタノールを製造す る方法を説明する。  Hereinafter, a method for producing ethanol by fermenting the yeast of the present invention in the presence of starch will be described.

本発明の酵母を、 まず、 好気的条件下で培養して、 その数を増加させる。 培地は、 選択培地であっても非選択培地であってもよい。 この酵母は、 デン プンを炭素源として生育可能であり、 培養時の培地中のデンプン濃度は、 可 溶性デンプンを用いる場合、 好ましくは約 1〜約 10g/l、 より好ましくは約 2〜約 6 g/l、 最も好ましくは約 4 g/lである。 また、 無蒸煮デンプンを用い る場合、 培地中のデンプン濃度は、 約 1〜約 50g/l、 好ましくは約 2〜約 40g /1、 さらに好ましくは約 10〜約 20g/lである。 培養時の培地の p Hは、 好ま しくは約 4. 0〜約 6. 0、 最も好ましくは約 5. 0である。 好気的培養時の培地中 P T/JP02/08234 The yeast of the present invention is first cultured under aerobic conditions to increase its number. The medium may be a selective medium or a non-selective medium. This yeast can be grown using starch as a carbon source, and the concentration of starch in the culture medium during culturing is preferably about 1 to about 10 g / l, more preferably about 2 to about 6 g when soluble starch is used. g / l, most preferably about 4 g / l. When uncooked starch is used, the concentration of starch in the medium is about 1 to about 50 g / l, preferably about 2 to about 40 g / 1, and more preferably about 10 to about 20 g / l. The pH of the culture medium during the culturing is preferably about 4.0 to about 6.0, most preferably about 5.0. In medium during aerobic culture PT / JP02 / 08234

12 の溶存酸素濃度は、 好ましくは約 0. 5〜約 6 ppm、 より好ましくは約 1〜約 4 ppm、 最も好ましくは約 2. Oppmである。 また、 培養時の温度は、 約 20〜約 4 5°C、 好ましくは約 25〜約 35°C、 最も好ましくは約 30°Cである。 培養は、 菌 体濃度が lOg/1以上になるまで培養することが好ましい。  The dissolved oxygen concentration of 12 is preferably about 0.5 to about 6 ppm, more preferably about 1 to about 4 ppm, and most preferably about 2.0 ppm. The temperature during the culturing is about 20 to about 45 ° C, preferably about 25 to about 35 ° C, and most preferably about 30 ° C. The culturing is preferably performed until the cell concentration reaches 10 g / l or more.

次いで、 本努明の酵母を、 嫌気的条件下で努酵させて、 エタノールを生産 させる。 この発酵工程の形式としては、 回分 (バッチ) 工程、 流加回分工程、 繰り返し回分工程、 連続工程などが挙げられるが、 これらのいずれであって あよい。  Next, the yeast of this effort is fermented under anaerobic conditions to produce ethanol. Examples of the form of this fermentation step include a batch (batch) step, a fed-batch batch step, a repeated batch step, a continuous step, and the like, and any of these may be used.

回分発酵工程とは、 予め発酵槽内に入れられた培地に酵母を接種すること によって行われる閉鎖的発酵法である。 流加回分工程とは、 上記回分工程に 対し、 栄養培地を供給しながら発酵させるが、 目的生産物はある時期に至る まで抜き取らない方法である。 繰り返し回分工程とは、 上記回分工程を、 繰 り返して行う工程である。 具体的には、 1回目の回分工程後、 培地と酵母と を分離して、 培地を抜き出し、 その後新鮮培地を新たに添加して発酵工程を 行う、 という操作が繰り返して行われる。 連続発酵工程とは、 発酵槽に新鮮 な培地を連続的に供給しながら、 同時に生産物 (すなわち、 エタノール) を 含む培地を発酵槽から抜き取つていく工程である。  The batch fermentation process is a closed fermentation method performed by inoculating yeast into a medium previously placed in a fermenter. In the fed-batch batch process, fermentation is performed while supplying a nutrient medium to the batch process, but the target product is not extracted until a certain time. The repeated batch process is a process in which the above batch process is repeated. Specifically, after the first batch process, the operation of separating the culture medium and yeast, extracting the culture medium, and then adding a fresh culture medium to perform the fermentation step is repeatedly performed. The continuous fermentation process is a process in which fresh medium is continuously supplied to the fermenter while simultaneously extracting the medium containing the product (ie, ethanol) from the fermenter.

回分式 (回分、 流加回分、 繰り返し回分) 工程の場合、 培地中のデンプン 濃度は、 好ましくは約 40〜約 150g/lである。 特に、 デンプン濃度は、 より好 ましくは約 50〜約 120g/l、 最も好ましくは約 60g/lである。 また、 連続工程 の場合、 添加デンプン濃度は、 好ましくは約 40〜約 300g/l、 より好ましくは 約 60〜約 250g/l、 最も好ましくは約 200g/lで維持される。 また、 無蒸煮デン プンを用いる場合、 培地中の仕込みデンプン濃度は、 約 50〜約 500g/l、 好ま しくは約 50〜約 400g/l、 さらに好ましくは約 150〜約 250g/lである。 発酵時 の培地の p Hは、 好ましくは約 4. 0〜約 6. 0、 最も好ましくは約 5. 0である。 缣気的発酵時の培地中の溶存酸素濃度は、 宿主となる酵母により異なるが、 好ましくは約 1. Oppm以下、 より好ましくは約 0. Ippm以下、 最も好ましくは約 0. 05ρριη以下である。 また、 発酵時の温度は、 約 20〜約 45°C、 好ましくは約 2 5〜約 35°C、 最も好ましくは約 30°Cである。 In the case of a batch (batch, fed-batch, repetitive batch) process, the starch concentration in the medium is preferably about 40 to about 150 g / l. In particular, the starch concentration is more preferably from about 50 to about 120 g / l, most preferably about 60 g / l. Also, in the case of a continuous process, the added starch concentration is preferably maintained at about 40 to about 300 g / l, more preferably about 60 to about 250 g / l, most preferably about 200 g / l. When non-steamed starch is used, the starch concentration in the medium is about 50 to about 500 g / l, preferably about 50 to about 400 g / l, and more preferably about 150 to about 250 g / l. The pH of the medium during fermentation is preferably from about 4.0 to about 6.0, most preferably about 5.0.溶 The dissolved oxygen concentration in the medium during aerial fermentation varies depending on the yeast used as the host, Preferably it is less than about 1.0 ppm, more preferably less than about 0.1 ppm, most preferably less than about 0.05 ρρη. The temperature during fermentation is about 20 to about 45 ° C, preferably about 25 to about 35 ° C, and most preferably about 30 ° C.

嫌気的発酵時の培地中の初期細胞濃度 (仕込み濃度) は、 酵母の種類、 培 地中のデンプン濃度などにより異なる力 S、 好ましくは初期 0D6。。は、 1 0〜 3 0 0、 より好ましくは 3 0〜: L 0 0である。 The initial cell concentration in the medium during anaerobic fermentation (charge concentration), type of yeast, the force varies by as starch concentration of culture ground S, preferably early 0D 6. . Is from 10 to 300, more preferably from 30 to: L00.

発酵の進行とともに上記の発酵条件が変化するので、 これらを一定の範囲 に調節することが好ましい。 発酵の経時変化は、 例えば、 ガスクロマトグラ フィ、 H P L Cなどの当業者が通常用レヽる手段でモニタ一すればよレ、。  Since the above fermentation conditions change as the fermentation progresses, it is preferable to adjust these to a certain range. Changes over time in the fermentation can be monitored by those skilled in the art, such as gas chromatography and HPLC, using ordinary methods.

発酵工程中または終了後、 エタノールを含む培地を発酵槽から抜き取り、 例えば、 遠心分離機による分離操作およぴ蒸留操作などの当業者が通常用い る分離工程によって、 エタノールが単離される。  During or after the fermentation step, the medium containing ethanol is withdrawn from the fermenter, and ethanol is isolated by a separation step commonly used by those skilled in the art such as a centrifugal separator and a distillation operation.

以下、 実施例を挙げて本発明を説明するが、 本発明はこれらの実施例によ つて限定されるものではない。 実施例  Hereinafter, the present invention will be described with reference to examples, but the present invention is not limited to these examples. Example

参考例 実験材料の調製  Reference example Preparation of experimental materials

(参考例 1 宿主酵母の育種)  (Reference Example 1 Breeding of host yeast)

凝集性酵母である Saccharomyces diastaticus ATCC60712 (MATa leu2- 3, 1 12 his2 lys2 stal FL08) およぴ非凝集性酵母である W303 - IB (ΜΑΤ α ura3- 52 trpl A 2 leu2— 3, 112 his3— 11 ade2— 1 canl-100) を用い、 M. D. Roseら (前出) の方法に従って、 トリブトファン栄養要求性の新たな凝集性の菌株 Y F 2 0 7 (MATa ura3-52 trpl Δ 2 his ade2- 1 canl-100 stal FL08) を得 た。  Saccharomyces diastaticus ATCC60712 (MATa leu2-3, 1 12 his2 lys2 stal FL08), which is an aggregating yeast, and W303-IB (ΜΑΤ α ura3-52 trpl A 2 leu2—3, 112 his3— 11, a non-aggregating yeast ade2—1 canl-100) and according to the method of MD Rose et al., supra, a new aggregating strain of tributofan auxotrophy, YF207 (MATa ura3-52 trpl Δ 2 his ade2-1 canl-). 100 stal FL08).

また、 非凝集性酵母である Saccharomyces cerevisiae MT 8— 1 (MATa ade his3 leu2 trpl ura3) (Tajimaら、 Yeast, 1 : 67-77, 1985) も、 宿主 酵母として用いた。 In addition, the non-aggregating yeast Saccharomyces cerevisiae MT 8-1 (MATa ade his3 leu2 trpl ura3) (Tajima et al., Yeast, 1: 67-77, 1985) Used as yeast.

(参考例 2 実施例おょぴ比較例に用いる各種プラスミ ドの調製) (Reference Example 2 Preparation of various plasmids used in Examples and Comparative Examples)

[2-1] Rhizopus oryzae由来のダルコアミラーゼを GP Iアンカーにより 細胞表層に提示するために用いるプラスミドの調製  [2-1] Preparation of plasmid used to display dalcoamylase from Rhizopus oryzae on cell surface by GPI anchor

Rhizopus oryzae由来のダルコアミラーゼを細胞表層に提示するマルチコ ピー型プラスミ ド p GAl 1は、 発明者である田中おょぴ植田らの文献 (Ap pi. and Environmental Microbiology (1997) 63: 1362 - 1366) に記載のもの を用いた。  The multicopy plasmid pGAl1, which presents the dalcoamylase from Rhizopus oryzae on the cell surface, is described by the inventor Tanaka Ope Ueda et al. (Appi. And Environmental Microbiology (1997) 63: 1362-1366). The one described in was used.

[2-2] Bacillus stearothermophilus由来の a—アミラーゼを G P Iアン カーにより細胞表層に提示するために用いるプラスミ ドの調製 [2-2] Preparation of plasmid used to display a-amylase from Bacillus stearothermophilus on cell surface by GPI anchor

Bacillus stearothermophilus由来の α—アミラーゼを細胞表層に提示す るプラスミ ド p AA1 2は、 プラスミド ρ I ΑΑΔ 1 1を出発材料として調 製した。 図 1にその構築の模式図を示す。 プラスミ ド ρ Ι ΑΑΔ 1 1を Xh o Iで処理し、 長断片と短断片とに分離した。  Plasmid p AA12, which presents α-amylase from Bacillus stearothermophilus on the cell surface, was prepared using plasmid ρIΑΑΔ11 as a starting material. Figure 1 shows a schematic diagram of the construction. Plasmid ρ Ι ΑΑΔ11 was treated with Xho I to separate it into a long fragment and a short fragment.

長断片をセルフライゲーシヨンして得られるプラスミ ドを No t Iおよび Kp n Iで切断し、 平滑化した後、 約 860 b pの断片を得た。 この断片は GAP DHプロモーター配列おょぴ α—ァグルチュンの 3 ' 側から 3 20ァ ミノ酸残基をコードする遺伝子配列を有する。 他方、 マルチコピー型プラス ミ ド ΡΜΤ 34 (+ 3) を、 Ρ V u I Iおよび B amH Iで切断し、 平滑ィ匕 した後、 上記約 860 b pの断片を糸且込んで、 プラスミ ド pUGP 1 2を得 た。  A plasmid obtained by self-ligating the long fragment was cut with NotI and KpnI and blunt-ended to obtain a fragment of about 860 bp. This fragment has a GAP DH promoter sequence and a gene sequence encoding 320 amino acid residues from the 3 ′ side of α-agglutin. On the other hand, the multicopy plasmid ΡΜΤ34 (+3) was digested with ΡVuII and BamHI, blunted, and the above fragment of about 860 bp was inserted into the plasmid to obtain plasmid pUGP1. I got 2.

プラスミド p I ΑΑΔ 1 1を Xh o Iで処理して得られた短断片は、 約 2 000 b の酵母の a—フ了クタ一の分泌シグナル配列おょぴ Bacillus ste arothermophilus由来の α—アミラーゼの成熟タンパク質配列をコードして いる。 この断片を、 上記プラスミド pUGP 12の Xh o I部位に導入して、 α—アミラーゼを細胞表層に提示するために用いるプラスミド pAAl 2を 得た。 [2-3] Bacillus stearothermophilus由来の α—アミラーゼを分泌するた めに用いるプラスミドの調製 A short fragment obtained by treating plasmid p I ΑΑΔ11 with Xho I was used to obtain a secretion signal sequence of about 2,000 b of the yeast a-functional enzyme. Α -amylase derived from Bacillus ste arothermophilus Encoding the mature protein sequence I have. This fragment was introduced into the XhoI site of the plasmid pUGP12 to obtain a plasmid pAAl2 used for displaying α-amylase on the cell surface. [2-3] Preparation of plasmid used to secrete α-amylase from Bacillus stearothermophilus

Bacillus stearothermophilus由来の ct一アミラーゼを分泌するプラスミ ド p SAAl 1は、 発明者である田中おょぴ植田らの文献 (Muraiら、 Appl. Microbiol. Biotechnol. (1999) 51:65-70) に記載の染色体組込み型プラ スミド p I AA1 1から α—アミラーゼ遺伝子を単離し、 これをマルチコピ 一プラスミド: UGP 3 (Takahashiら、 Appl. Microbiol. Biotechnol. (2 001) 55:454-462) に組込むことにより調製した。 図 2にその構築の模式図 を示す。 : I A A 1 1をテンプレートとし、 5' - ATGCGAGCTCATGAGATTTCCTCCA ATTTTTACTGCAG-3' (配列番号 1 ) および 5' -ATGCGAGCTCTCAAGGCCATGCCACCAAC CGTGGTTCGG- 3' (配列番号 2) をプライマーとして用いて、 PCRを行い、 S a c Iで切断して約 2000 b pの長さの断片を得た。 この断片は、 酵母 の α—ファタターの分泌シグナル配列おょぴ α—ァミラーゼの成熟タンパク 質配列をコードしていた。 得られた配列を、 予め S a c I処理した pUGP 3に連結し、 プラスミド p SAA1 1を得た。  Plasmid pSAAl1, which secretes ct-amylase from Bacillus stearothermophilus, is described in the literature of the inventor Tanaka Ope Ueda et al. (Murai et al., Appl. Microbiol. Biotechnol. (1999) 51: 65-70). The α-amylase gene was isolated from the chromosome-integrated plasmid pIAAA1 of the above, and this was integrated into a multicopy plasmid: UGP 3 (Takahashi et al., Appl. Microbiol. Biotechnol. (2 001) 55: 454-462). Prepared by Figure 2 shows a schematic diagram of the construction. : Perform PCR using IAA11 as a template, 5'-ATCGCGAGCTCATGAGATTTCCTCCA ATTTTTACTGCAG-3 '(SEQ ID NO: 1) and 5'-ATGCGAGCTCTCAAGGCCATGCCACCAAC CGTGGTTCGG-3' (SEQ ID NO: 2) as primers and cut with SacI As a result, a fragment having a length of about 2000 bp was obtained. This fragment encoded the secretory signal sequence of yeast α-fatty acid and the mature protein sequence of α-amylase. The obtained sequence was ligated to pUGP3 previously treated with SacI to obtain a plasmid pSAA11.

[2-4] Rhizopus oryzae由来のダルコアミラーゼを分泌するために用いる プラスミ ドの調製 [2-4] Preparation of plasmid used to secrete darcoamylase from Rhizopus oryzae

Rhizopus oryzae由来のダルコアミラーゼを分泌するプラスミド p SGA 11は、 図 3に示す方法で作成した。 pGAl 1をテンプレートとし、 ブラ イマ一として、 5, - ATCGGGATCCATGCMCTGTTC TTTGCCATTGAAAGTT- 3' (配列番 号 3) 、 および 5, - ATCGGTCGACTTMGCGGCAGGTGCACCAGCCTTAGCGTA- 3, (配列番 号 4) を用いて PC R増幅を行い、 制限酵素 B amH Iおよび S a 1 Iで切 断して、 約 1800 b pの B amH I— S a 1 I断片を得た。 この断片は、 ダルコアミラーゼの分泌シグナル配列およびダルコアミラーゼの成熟タンパ ク質配列をコードしている。 他方、 マルチコピー型プラスミ ド p UGP 3 (Takahashiら、 同上) を制限酵素 B a mH Iおよび S a 1 Iで切断し、 そ こに上記約 1800 b pの B amH I— S a 1 I断片を連結して、 グルコア ミラーゼを分泌するために用いるプラスミ ド p SGAl 1を作成した。 Plasmid pSGA11 secreting darcoamylase from Rhizopus oryzae was prepared by the method shown in FIG. Using pGAl1 as a template and a primer, 5,-ATCGGGATCCATGCMCTGTTC TTTGCCATTGAAAGTT-3 '(sequence number 3) and 5,-ATCGGTCGACTTMGCGGCAGGTGCACCAGCCTTAGCGTA-3, (sequence number PCR amplification was carried out using No. 4), followed by digestion with restriction enzymes BamHI and Sa1I to obtain a BamHI-Sa1I fragment of about 1800 bp. This fragment encodes the secretory signal sequence of dalcoamylase and the mature protein sequence of dalcoamylase. On the other hand, the multicopy plasmid p UGP3 (Takahashi et al., Supra) was digested with restriction enzymes BamHI and Sa1I, and the above-mentioned BamHI-Sa1I fragment of about 1800 bp was added thereto. Ligation produced the plasmid pSGAl1 used to secrete glycoamylase.

[2-5] Streptococcus bovis由来のひ一アミラーゼを G P Iアンカーによ り細胞表層に提示するために用いるプラスミ ドの調製 [2-5] Preparation of plasmid used to display human amylase from Streptococcus bovis on cell surface by GPI anchor

Streptococcus bovis 148由来の α—アミラーゼを細胞表層に提示するプ ラスミド pBAAlは、 上記 [a- 2] で得られたプラスミ ド p A A 12を出 発材料として調製した。 図 4にプラスミ ド pBAAlの模式図を示す。 ブラ スミ ド pAAl 2を Xh o Iで処理し、 長断片 (6.9kb) と短断片 (1.7kb) とに分離した。  Plasmid pBAAl which presents α-amylase derived from Streptococcus bovis 148 on the cell surface was prepared using plasmid pAA12 obtained in the above [a-2] as a starting material. Figure 4 shows a schematic diagram of the plasmid pBAAl. The plasmid pAAl2 was treated with XhoI and separated into a long fragment (6.9 kb) and a short fragment (1.7 kb).

長断片をセルフライゲーシヨンして得られるプラスミ ドを No t Iおよび Kp n Iで切断し、 平滑化した後、 約 860 b pの断片を得た。 この断片は GAPDHプロモーター配列おょぴ α—ァグルチニンの 3' 側から 320ァ ミノ酸残基をコードする遺伝子配列を有する。 他方、 マルチコピー型プラス ミ ド ρΜΤ 34 (+ 3) を、 Ρ V u I Iおよび B amH Iで切断し、 平滑化 した後、 上記約 860 b pの断片を組込んで、 プラスミ ド pUGP 12を得 た。  A plasmid obtained by self-ligating the long fragment was cut with NotI and KpnI and blunt-ended to obtain a fragment of about 860 bp. This fragment has a GAPDH promoter sequence and a gene sequence encoding 320 amino acid residues from the 3 ′ side of α-agglutinin. On the other hand, the multicopy plasmid ρΜΤ34 (+3) was digested with ΡVuII and BamHI, blunted, and the above fragment of about 860 bp was incorporated to obtain plasmid pUGP12. Was.

プラスミ ド!) QE 31 (キアゲン社) に Streptococcus bovis 418由来の α—アミラーゼ遺伝子 (E. Satohら、 Appl. Environ. Microbiol. 63 :4593 - 4 596 (1997)) が挿入されたプラスミド!) QE 31 : : amyAを作成した。 これを S a c I Iおよび Xh o Iで切断して、 S. bovis 418由来の 一アミ ラーゼ遺伝子を含む断片を得た。 次いで、 プラスミ ド p CAS l (S. Shibas akiら、 Appl. Microbiol. Biotechnol. 55:471—475 (2001)) を S a c I I および X h o Iで切断し、 そこに S. bovis 418由来の α—アミラーゼ遺伝子 断片を揷入して、 プラスミド p C AS 1:: a my Aを得た。 このプラスミド p CAS 1:: a my Aをテンプレートとして、 5' -AATACTCGAGATGCAACTGTTCAPlus! A plasmid in which an α-amylase gene derived from Streptococcus bovis 418 (E. Satoh et al., Appl. Environ. Microbiol. 63: 4593-4596 (1997)) was inserted into QE31 (Qiagen)! ) QE31 :: AmyA was created. This was digested with Sac II and Xho I to obtain a single amino acid from S. bovis 418. A fragment containing the lase gene was obtained. Next, plasmid pCASl (S. Shibasaki et al., Appl. Microbiol. Biotechnol. 55: 471-475 (2001)) was digested with SacII and XhoI, and α-derived from S. bovis 418 was added thereto. —Amylase gene fragment was inserted to obtain plasmid pCAS1 :: amyA. 5'-AATACTCGAGATGCAACTGTTCA using this plasmid pCAS1 :: amyA as a template

ATTTGCCATTGAAAGT- 3, (配列番号 5 ) およぴ 5, -CTGCCCATGGGGTTTTAGCCCATCTT TATTATAGTTTCC-3' (配列番号 6) のプライマーを用いる P C Rによって増幅 し、 Xh o lで処理し、 ダルコアミラーゼ遺伝子の分泌シグナル配列おょぴ Streptococcus bovis 148由来の α—アミラーゼ遺伝子を含む 2. 2 k bの DNA断片を得た。 この断片を、 上記プラスミ ド pUGP 12の Xh o I部 位に導入して、 Streptococcus bovis由来の α—アミラーゼを細胞表層に提 示するために用いるプラスミド; BAAlを得た。 ATTTGCCATTGAAAGT-3, (SEQ ID NO: 5) and 5, -CTGCCCATGGGGTTTTAGCCCATCTT TATTATAGTTTCC-3 '(SEQ ID NO: 6) Amplified by PCR, treated with Xhol, and secreted signal sequence of dalcoamylase gene. A 2.2 kb DNA fragment containing the α-amylase gene derived from Streptococcus bovis 148 was obtained. This fragment was introduced into the XhoI site of the plasmid pUGP12 to obtain BAAl, a plasmid used to display α-amylase derived from Streptococcus bovis on the cell surface.

[2-6] Streptococcus bovis由来の a—アミラーゼを分泌するために用い るプラスミ ドの調製 [2-6] Preparation of plasmid used to secrete a-amylase from Streptococcus bovis

Streptococcus bovis 148由来の a—アミラーゼを分泌するプラスミド p S BAA 2の模式図を、 図 5に示す。 プラスミド p CAS 1:: amyAをテ ンプレートとして、 プライマーとして、 5' -AATAGAGCTCATGCAACTGTTCAATTTGC CATTGAAAGT - 3, (配列番号 7 ) およぴ 5' - TGGCGGTACCTTATTTTAGCCCATCTTTATTA TAGTTTC-3' (配列番号 8) のプライマーを用いる P CRによって増幅し、 制 限酵素 S a c Iおよび Kp n Iで切断し、 ダルコアミラーゼの分泌シグナル 配列おょぴダルコアミラーゼの成熟タンパク質配列をコードする 2. 2 k b の DNA断片を得た。 他方、 マルチコピー型プラスミド pUGP 3 (Takaha shiら、 同上) を制限酵素 S a c Iおよび Kp n Iで切断し、 そこに上記 S a c I一 Κρ n I断片を連結して、 Streptococcus bovis由来の α—ァミラ ーゼを分泌するために用いるプラスミド p SBAA2を作成した。 [2-7] Rhizopus oryzae由来のグルコアミラーゼおょぴ Streptococcus bo vis由来の α—ァミラーゼを凝集機能ドメインとの融合タンパク質として細 胞表層に提示するために用いるプラスミドの調製 FIG. 5 shows a schematic diagram of the plasmid pSBAA2 that secretes a-amylase derived from Streptococcus bovis 148. Plasmid p CAS 1 :: Using amyA as a template, primers 5'-AATAGAGCTCATGCAACTGTTCAATTTGC CATTGAAAGT-3, (SEQ ID NO: 7) and 5'-TGGCGGTACCTTATTTTAGCCCATCTTTATTA TAGTTTC-3 '(SEQ ID NO: 8) Amplified by CR and digested with restriction enzymes SacI and KpnI, a 2.2 kb DNA fragment encoding the secretory signal sequence of dalcoamylase and the mature protein sequence of dalcoamylase was obtained. On the other hand, the multicopy-type plasmid pUGP3 (Takaha shi et al., Supra) was digested with restriction enzymes SacI and KpnI, and the above SacI- nρnI fragment was ligated therewith, thereby obtaining Streptococcus bovis-derived α. A plasmid pSBAA2 used to secrete amylase was constructed. [2-7] Preparation of plasmid used to display glucoamylase derived from Rhizopus oryzae α-amylase from Streptococcus bo vis as a fusion protein with the aggregation function domain on the cell surface

[2-7-1] prepro α - factorシグナル配列遺伝子の取得  [2-7-1] Acquisition of prepro α-factor signal sequence gene

次のようにして prepro a- factorシグナル配列遺伝子を取得した。 S. cer evisiae W303- IBの染色体 D N Aを抽出した。 これをテンプレートとし、 プ ライマーとして 5, -AACGGAGCTCATGAGATTTCCTTCAATTTTTACTGCAGTT-3' (配列番 号 9 ) およぴ 5, -GGGGTACCGCATGCTCTTTTATCCAAAGATACCCCTTCTTCTTT-3' (配列 番号 10) を用いて PC R増幅した。 増幅物を、 3 &。 1ぉょぴ1 13111で 消化して、 約 250 b ρの長さの prepro ひ- factorシグナル配列の S a c I -Kpn I断片を得た。  The prepro a-factor signal sequence gene was obtained as follows. Chromosome DNA of S. cer evisiae W303-IB was extracted. Using this as a template, PCR amplification was performed using 5, -AACGGAGCTCATGAGATTTCCTTCAATTTTTACTGCAGTT-3 '(SEQ ID NO: 9) and 5, -GGGGTACCGCATGCTCTTTTATCCAAAGATACCCCTTCTTCTTT-3' (SEQ ID NO: 10) as primers. Amplify 3 &. After digestion with 1 ぉ 113111, a SacI-KpnI fragment of a prepro-factor signal sequence of about 250 bρ in length was obtained.

[2-7-2] F L O 1の 5, 領域 (凝集機能ドメイン) の遺伝子の取得 FLO 1の 5' 領域 (凝集機能ドメイン) の遺伝子を、 次のようにして取 得した。 まず、 S. cerevisiae ATCC60715から染色体 DNAを抽出した。 次 いで、 これをテンプレートとし、 プライマーとして 5' - AGGAGGATCCGAGGCGTGC TTACCAGCAGGCCAGAGGAAA-3' (配列番号 1 1) および 5, - GCGAGTCGACTTMGATCT GGTGATTTGTCCTGAAGATGATGATGACAAA-3' (配列番号 12 ) を用いて P C R増幅 し、 増幅物を B amH Iおよび S a 1 Iで消化して、 約 3300 b j)の長さ の B a mH I— S a 1 I断片を得た。 この断片は、 F L O 1の 5 ' 側の分泌 シグナル配列を除く F L O 1凝集機能ドメインをコードしており、 Watariら の報告 (Yeast 10(2): 211-25 (1994) ) に記載の配列と一致するものであつ [2-7-3] Rhizopus oryzaeのダルコアミラーゼ遺伝子の取得 Rhizopus oryzaeのダルコアミラーゼ遺伝子を以下のようにして取得した。 簡単に述べると、 まず、 ダルコアミラーゼ遺伝子を含むプラスミド p GA1 1をテンプレートとし、 プライマーとして 5' -CGTTGGATCCGCAAGCATTCCTAGT AGTGCTTCTGTCCAG- 3, (配列番号 13) および 5' - ATCGGGATCCAGCGGCAGGTGCACC AGCCTTAGCGTA-3' (配列番号 14) を用いて P C R増幅を行い、 増幅物を B a mH Iで消化して約 1800 b pのダルコアミラーゼ遺伝子 B a mH I断 片を得た。 この断片は、 ダルコァミラーゼの分泌シグナル配列を除く成熟タ ンパク質配列をコードしていた。 [2-7-2] Acquisition of the gene for the 5 region (aggregating functional domain) of FLO 1 The gene for the 5 'region (aggregating functional domain) of FLO 1 was obtained as follows. First, chromosomal DNA was extracted from S. cerevisiae ATCC60715. Then, using this as a template, PCR amplification was performed using 5'-AGGAGGATCCGAGGCGTGC TTACCAGCAGGCCAGAGGAAA-3 '(SEQ ID NO: 11) and 5, -GCGAGTCGACTTMGATCT GGTGATTTGTCCTGAAGATGATGATGACAAA-3' (SEQ ID NO: 12) as primers, and the amplified product was BamH. Digestion with I and Sa1I resulted in a BamHI-Sa1I fragment of approximately 3300 bj) in length. This fragment encodes the FLO1 aggregation functional domain except for the secretory signal sequence on the 5 'side of FLO1, and has the sequence described in Watari et al. (Yeast 10 (2): 211-25 (1994)). Matches [2-7-3] Acquisition of darcoamylase gene of Rhizopus oryzae The darcoamylase gene of Rhizopus oryzae was acquired as follows. Briefly, first, the plasmid pGA11 containing the darcoamylase gene was used as a template, and 5'-CGTTGGATCCGCAAGCATTCCTAGT AGTGCTTCTGTCCAG-3, (SEQ ID NO: 13) and 5'-ATCGGGATCCAGCGGCAGGTGCACC AGCCTTAGCGTA-3 '(SEQ ID NO: 14) were used as primers. The amplified product was digested with BamHI to obtain an approximately 1800 bp dalcoamylase gene BamHI fragment. This fragment encoded the mature protein sequence excluding the secretory signal sequence of dalcoamylase.

[2-7-4] Streptococcus bovisの α—アミラーゼ遺伝子の取得 [2-7-4] Acquisition of α-amylase gene of Streptococcus bovis

Streptococcus bovisの α—アミラーゼ遺伝子を以下のようにして取得し た。 簡単に述べると、 まず、 α—アミラーゼ遺伝子を含むプラスミ ド pQE 31 : : a my Aをテンプレートとし、 プライマーとして 5, - CGTTAGATCTGAT GAACAAGTGTCAATGAAAGATGGTACG-3' (配列番号 15) およぴ 5' - ATMCTCGAGTTA TTTTAGCCCATCTTTATTATAGTTTCC-3' (配列番号 16 ) を用いて P C R増幅を行 い、 増幅物を B g 1 I Iおよび Xh o Iで消化して、 約 2000 b pの α— アミラーゼ遺伝子 B g 1 I I -Xh o I断片を得た。 この断片は、 ひーアミ ラーゼの分泌シグナル配列を除く成熟タンパク質配列をコードしていた。  The α-amylase gene of Streptococcus bovis was obtained as follows. Briefly, first, plasmid pQE31 :: amyA containing the α-amylase gene was used as a template, and 5,-CGTTAGATCTGAT GAACAAGTGTCAATGAAAGATGGTACG-3 '(SEQ ID NO: 15) and 5'-ATMCTCGAGTTA TTTTAGCCCATCTTTATTATAGTTTCC- PCR amplification was performed using 3 ′ (SEQ ID NO: 16), and the amplified product was digested with Bg1II and XhoI to obtain an approximately 2000 bp α-amylase gene Bg1II-XhoI fragment. Obtained. This fragment encoded the mature protein sequence except for the secretory signal sequence of the heat amylase.

[2-7-5] 酵母表層提示用プラスミ ドの調製 [2-7-5] Preparation of plasmid for yeast surface display

まず、 クローニングプラスミ ド pUC 1 1 9を S a c Iおよび Kp η Iで 消化後、 上記 [2-7-1] で得られた prepro a -factorシグナル配列の S a c I -Kp n I断片を挿入して、 プラスミ ド; UC 1 1 9 αを得た。 このプラ スミ ド pUC 1 1 9 αを、 B amH Iおよび S a 1 Iで消ィ匕して、 上記 [2 - 7-2] で得られた FLO 1遺伝子の B amH I _S a 1 I断片を挿入して、 p UC 1 1 9 a F Sを得た。 このプラスミ ド p UC 1 1 9 o;FSを S a c l および S a 1 Iで消化後、 得られた約 3500 b pの aF S遺伝子 S a c I -S a i l断片を、 S a c Iおよび S a 1 Iで消化した酵母構成的発現用プ ラスミド pWGP 3に挿入し、 酵母表層提示用プラスミド pWGaF Sを得 た。 First, after cloning plasmid pUC119 was digested with SacI and KpηI, the SacI-KpnI fragment of the prepro a-factor signal sequence obtained in [2-7-1] was inserted. Then, plasmid; UC119α was obtained. This plasmid pUC119α was digested with BamHI and Sa1I, and the BamHI_Sa1I fragment of the FLO1 gene obtained in [2-7-2] above was obtained. And insert p UC 1 19 a FS was obtained. The plasmid p UC 1 1 9 o; was digested FS in S acl and S a 1 I, the a FS gene S ac I -S ail fragment obtained about 3500 bp, S ac I and S a 1 I The plasmid was inserted into the yeast constitutive expression plasmid pWGP3 digested with, and the yeast surface display plasmid pWGaFS was obtained.

[2-7-6] Streptococcus bovis由来の α—アミラーゼを凝集機能ドメイン により細胞表層に提示するために用いるプラスミ ドの調製 [2-7-6] Preparation of plasmid used to display α-amylase from Streptococcus bovis on cell surface by using aggregation domain

上記 [2-7-5] で得られた酵母表層提示用プラスミド pWGaFSを、 B g 1 I Iおよび Xh o Iで消化後、 上記 [2-7-4] で得られた 一アミラー ゼ遺伝子 B g 1 I I -Xh o I断片を挿入して、 ひ一アミラーゼ表層提示用 プラスミド pWGaFSAを得た。 なお、 α—アミラーゼは、 FLOl凝集 機能ドメインの C末端側に融合された融合タンパク質として発現する。  After digesting the plasmid pWGaFS for yeast surface display obtained in [2-7-5] above with Bg1II and XhoI, the monoamylase gene Bg obtained in [2-7-4] above is digested. The 1II-XhoI fragment was inserted to obtain a plasmid for surface display of human amylase pWGaFSA. Α-amylase is expressed as a fusion protein fused to the C-terminal side of the FLOl aggregation functional domain.

[2-7-7] Rhizopus oryzae由来のグルコアミラーゼぉょぴ Streptococcus bovis由来の 一アミラーゼを融合タンパク質として細胞表層に提示するた めに用いるプラスミドの調製 [2-7-7] Glucoamylase from Rhizopus oryzae Preparation of plasmid used to display a single amylase from Streptococcus bovis as a fusion protein on cell surface

上記 [2 - 7- 6] で得られたプラスミド p WG aF SAを B amHIで消化 後、 脱リン酸化を行い、 上記 [2 - 7- 3] で得られたダルコアミラーゼ遺伝子 B amH I断片を挿入して、 ダルコアミラーゼおよび α—アミラーゼを融合 タンパク質として細胞表層に提示するためのプラスミド pWGaGF S Αプ ラスミドを得た。 ダルコアミラーゼおよび α—アミラーゼは、 FLOl凝集 機能ドメインのそれぞれ Ν末端側おょぴ C末端側に融合された融 1 質として発現する。 [2-8] Rhizopus oryzae由来のダルコアミラーゼを凝集機能ドメインによ り細胞表層に提示するために用いるプラスミドの調製 The plasmid pWGaFSA obtained in [2-7-6] is digested with BamHI, dephosphorylated, and the dalcoamylase gene BamHI fragment obtained in [2-7-3] is digested. By insertion, a plasmid pWGaGF S plasmid for displaying dalcoamylase and α-amylase as a fusion protein on the cell surface was obtained. Dalcoamylase and α-amylase are expressed as fusion proteins fused to the C-terminal side of the FLOL aggregation functional domain. [2-8] Preparation of plasmid used to display dalcoamylase from Rhizopus oryzae on the cell surface by using the aggregation functional domain

上記 [2-7-5] で得られた酵母表層提示用プラスミド pWGaFSを、 B amH Iで消化後、 脱リン酸化を行い、 上記 [2-7-3] で得られたダルコア ミラーゼ遺伝子 B a mH I断片を挿入して、 ダルコアミラーゼ表層提示用プ ラスミド p WG aGF Sを得た。 なお、 ダルコアミラーゼは、 F L O 1凝集 機能ドメインの N末端側に融合された融合タンパク質として発現する。  The plasmid pWGaFS for yeast surface display obtained in [2-7-5] is digested with BamHI, dephosphorylated, and the darcoamylase gene B a obtained in [2-7-3] is obtained. The mHI fragment was inserted to obtain a plasmid pWGaGFS for display on the surface of Dalcoamylase. The darcoamylase is expressed as a fusion protein fused to the N-terminal side of the FLO1 aggregation functional domain.

(実施例 1 '· Rhizopus oryzae由来のダルコアミラーゼを GP Iアンカー により細胞表層に提示し力、つ Bacillus stearothermophilus由来のひ一アミ ラーゼを分泌する凝集性酵母の作成) (Example 1) Preparation of a flocculant yeast which presents dalcoamylase derived from Rhizopus oryzae on the cell surface by means of a GPI anchor and secretes human amylase derived from Bacillus stearothermophilus.

Rhizopus oryzae由来のダルコアミラーゼを GP Iアンカーにより細胞表 層に提示するためのプラスミド: GAl 1と Bacillus stearothermophilus 由来の α—アミラーゼを分泌するためのプラスミド; S AA1 1とを、 Yeas t Maker (Clontech Laboratories, Inc., Palo Alto, CA)を用いた酢酸リチ ゥム法によって、 同時に酵母 YF 207に導入した。 これを、 選択培地とし て、 L一トリプトファンおょぴゥラシルを含まない適切なアミノ酸および塩 基を補充した SD寒天培地 (6.7g/l Yeast nitrogen base w/o amino acids (Difco Laboratories製) 、 2%グルコース、 0· 02g/l硫酸アデニン、 0.02g/ 1 L -ヒスチジン ·1Κ1、 0.03g/l L-ロイシン、 0.02g/l L-リジン) を用いて、 培養した。 生育した酵母を選択し、 YF 207ノ pGAl 1 +P SAA1 1 と命名した。  Plasmids for displaying dalcoamylase from Rhizopus oryzae on the cell surface with a GPI anchor: GAl1 and a plasmid for secreting α-amylase from Bacillus stearothermophilus; SAA1 1 and Yeast Maker (Clontech Laboratories , Inc., Palo Alto, Calif.) Was simultaneously introduced into yeast YF207 by the lithium acetate method. This was used as a selective medium, SD agar medium (6.7 g / l Yeast nitrogen base w / o amino acids (Difco Laboratories)) supplemented with appropriate amino acids and bases not containing L-tryptophan or uracil, 2 % Glucose, 0.02 g / l adenine sulfate, 0.02 g / 1 L-histidine / 1Κ1, 0.03 g / l L-leucine, 0.02 g / l L-lysine). The grown yeast was selected and named as YF207-pGAl1 + PSAA11.

(比較例 1 : Rhizopus oryzae由来のダルコアミラーゼおよび Bacillus st earothermophilus由来の α—アミラーゼをそれぞれ GP Iアンカーにより細 胞表層に提示する凝集性酵母の作成) Rhizopus oryzae由来のダルコアミラーゼを GP Iアンカーにより細胞表 層に提示するためのプラスミド: GAl 1と Bacillus stearothermophilus 由来の α—アミラーゼを細胞表層に提示するためのプラスミド pAAl 2と を、 実施例 1と同様に酵母 YF 207に同時に導入し、 得られた酵母を YF 207/pGAl 1 + p AA12と命名した。 (Comparative Example 1: Preparation of flocculent yeast that presents Dalcoamylase derived from Rhizopus oryzae and α-amylase derived from Bacillus stearothermophilus to the cell surface using a GPI anchor, respectively) Plasmid for displaying Rhizopus oryzae-derived darcoamylase on the cell surface with a GPI anchor: GAl1 and plasmid pAAl2 for displaying Bacillus stearothermophilus-derived α-amylase on the cell surface in the same manner as in Example 1. At the same time, and the resulting yeast was named YF207 / pGAl1 + pAA12.

(比較例 2: Rhizopus oryzae由来のダルコアミラーゼを分泌しかつ Bacil lus stearothermophilus由来の α—アミラーゼを GP Iアンカーにより細胞 表層に提示する酵母の作成) (Comparative Example 2: Preparation of yeast that secretes darcoamylase derived from Rhizopus oryzae and displays α-amylase derived from Bacil lus stearothermophilus on the cell surface using a GPI anchor)

ダルコアミラーゼを分泌するためのプラスミド p SGA1 1と α—ァミラ ーゼを GP Iアンカーにより細胞表層に提示するためのプラスミド pAAl 2とを、 実施例 1と同様に酵母 YF 207に同時に導入し、 得られた酵母を YF 20 Ί /v SGA11 + p AA12と命名した。 (比較例 3 : Rhizopus oryzae由来のダルコアミラーゼを G P Iアンカー により細胞表層に提示する凝集性酵母の作成)  Plasmid pSGA11 for secreting dalcoamylase and plasmid pAAl2 for displaying α-amylase on the cell surface by GPI anchor were simultaneously introduced into yeast YF207 in the same manner as in Example 1. The obtained yeast was designated as YF20Ί / v SGA11 + pAA12. (Comparative Example 3: Preparation of flocculent yeast displaying Dalcoamylase from Rhizopus oryzae on the cell surface by GPI anchor)

Rhizopus oryzae由来のダルコアミラーゼを細胞表層に提示するためのプ ラスミド pGAl 1を用い、 選択培地にゥラシル lOg/1を加えた以外は実施 例 1'と同様にして、 プラスミド pGAl 1を酵母 YF 207に導入し、 得ら れた酵母を YF 207/pGAl 1と命名した。  Plasmid pGAl1 was transferred to yeast YF207 in the same manner as in Example 1 ', except that plasmid pGAl1 for presenting darcoamylase derived from Rhizopus oryzae on the cell surface was used, and peracyl lOg / 1 was added to the selection medium. The yeast thus introduced and obtained was named YF207 / pGAl1.

(実施例 2、 比較例 4〜6) (Example 2, Comparative Examples 4 to 6)

実施例 1、 比較例 1〜 3で得られた形質転換酵母各 5 mlを、 1 %カザミノ 酸 (Difco Laboratories製) を含む S D培地 100mlにそれぞれ接種し、 30°C にて 48時間振とうすることによって、 種培養を行った。  Each 5 ml of the transformed yeast obtained in Example 1 and Comparative Examples 1 to 3 was inoculated into 100 ml of SD medium containing 1% casamino acid (manufactured by Difco Laboratories), and shaken at 30 ° C. for 48 hours. Thus, seed culture was performed.

次いで、 各 50mlの種培養物を、 1Lの 4%YPS培地 (lOg/1 酵母エキストラ タト (D co Laboratories製) 、 20g/l ポリペプトン (和光純薬 (株)製) 、 40g/l デンプン (可溶性) (和光純薬 (株)製) 、 5g/l グルコース) を予め 入れた 2 Lのジャーフアーメンター (BMJ- 02PI、 Biott Corp. , 東京) にそれ ぞれ入れ、 30°Cにて好気的条件下で培養した。 培地の p Hを、 硫酸おょぴ水 酸ィ匕ナトリウムの添加によって 5, 0に維持し、 そして溶存酸素濃度 (D O) を、 撹拌速度を調節することによって 2. Oppmに維持した。 乾燥菌体重量が約 15g/lに達した後、 培地を抜き取って、 5000rpmでの 10分間の遠心分離によつ て菌体を回収した。 Then, 50 ml of each seed culture was added to 1 L of 4% YPS medium (10 g / l Og / 1 yeast extra Tato (manufactured by Dco Laboratories), 20 g / l polypeptone (manufactured by Wako Pure Chemical Industries, Ltd.), 40 g / l starch (soluble) (manufactured by Wako Pure Chemical Industries, Ltd.), 5 g / l glucose were pre-filled. Each was placed in a 2 L jar armmenter (BMJ-02PI, Biott Corp., Tokyo) and cultured at 30 ° C under aerobic conditions. The pH of the medium was maintained at 5.0 by the addition of sodium sulfate sulfate, and the dissolved oxygen concentration (DO) was maintained at 2.0 ppm by adjusting the stirring speed. After the weight of the dried cells reached about 15 g / l, the medium was removed, and the cells were collected by centrifugation at 5000 rpm for 10 minutes.

なお、 用いた酵母の宿主である酵母 Y F 2 0 7株は、 この培地では、 ほと んど生育しなかった。  The yeast strain YF207, which is a host of the yeast used, hardly grew in this medium.

得られた酵母菌株を用いて、 それぞれ回分発酵を行いエタノールを生産さ せた。 すなわち、 回収した各酵母ペレッ トを、 ジャーフアーメンター中の 1 Lの 6 %YPS培地 (すなわち、 60g/lのデンプンを含む) に接種し、 p H5. 0、 30°Cにて嫌気的条件下で緩やかに撹拌 (150rpm) しながら約 35時間発酵を行 つた。 培養および発酵工程を通して、 デンプン濃度、 乾燥菌体重量、 および ェタノ一/レ濃度を測定した。  Using the obtained yeast strain, batch fermentation was performed to produce ethanol. That is, each of the collected yeast pellets is inoculated into 1 L of 6% YPS medium (that is, containing 60 g / l starch) in a jar arm mentor, and subjected to anaerobic conditions at pH 5.0 and 30 ° C. Fermentation was carried out for about 35 hours with gentle stirring (150 rpm) underneath. Throughout the cultivation and fermentation steps, starch concentration, dry cell weight, and ethanol concentration were determined.

デンプン濃度は、 以下のように測定した。 1. 0mlの試料から、 5000rpmで 5 分間遠心分離によって菌体を分離し、 上清を蒸留水で希釈して、 デンプン濃 度測定に使用した。 Aspergillus niger由来のダルコアミラーゼ溶液 (6100 ユニット /ml、 Sigma Chemical Co. , St. Louis, M0) を蒸留水で 100倍希釈 し、 0. 9mlの希釈した試料に 0. lmlのダルコアミラーゼ溶液を加えて、 30°Cに て 30分間インキュベートした。 反応を 10分間の煮沸によって停止した後、 溶 液中のグルコース濃度を、 グルコース CIIテストヮコー (和光純薬 (株)製) を用い、 分光光度計 (U-2001、 日立製) を使用して測定し、 デンプン濃度に 換算した。 The starch concentration was measured as follows. Cells were separated from the 1.0 ml sample by centrifugation at 5000 rpm for 5 minutes, and the supernatant was diluted with distilled water and used for starch concentration measurement. From Aspergillus niger of Darco amylase solution (6100 units / m l, Sigma Chemical Co., St. Louis, M0) were diluted 100-fold with distilled water, Darco amylase solution 0. lml the diluted sample of 0. 9 ml In addition, it was incubated at 30 ° C for 30 minutes. After the reaction was stopped by boiling for 10 minutes, the glucose concentration in the solution was measured using a glucose CII Test Co. (Wako Pure Chemical Industries, Ltd.) and a spectrophotometer (U-2001, Hitachi). And converted to starch concentration.

また、 エタノール濃度は、 水素炎イオン化検出器を装着したガスクロマト PC漏膽 34 The ethanol concentration was measured using a gas chromatograph equipped with a flame ionization detector. PC Cough 34

24 グラフ (Model GC-8 ; 島津製作所製) を使用して測定した。 測定条件は以下 のとおりであった:カラム、 3. 0脇 X 3. lmのガラスに充填された Unisole 300 0 (GL Science Inc. ) ;カラム温度、 210°C;インジェクター/検出器の温度、 270°C;キャリアガス、 窒素 (流速: 25ml/分) 。  The measurement was performed using 24 graphs (Model GC-8; manufactured by Shimadzu Corporation). The measurement conditions were as follows: column, 3.0 side x 3.30 lm of Unisole 300 0 (GL Science Inc.) packed in glass; column temperature, 210 ° C; injector / detector temperature, 270 ° C; carrier gas, nitrogen (flow rate: 25 ml / min).

各種酵母の增殖および流加回分培養によるアルコール発酵の結果を表 1に 示す。 なお、 表 1中、 feed l、 feed 2とあるのは、 それぞれ、 3 6時間目お よび 7 2時間目のデンプン濃度測定後に追カ卩したデンプン量 (g ) を意味し、 それ以外の数字は、 培地中のデンプン濃度 (g/1) を意味する。 Table 1 shows the results of alcohol fermentation by cultivation and fed-batch culture of various yeasts. In Table 1, feed l and feed 2 indicate the amount of starch (g) added after the measurement of the starch concentration at 36 hours and 72 hours, respectively. Means the starch concentration (g / 1) in the medium.

IN3 IN3

o  o

Figure imgf000027_0001
Figure imgf000027_0001

*1 GA:グルコアミラーゼ *3 (アルコ-ル生産量 添加 τンプン量) X 100 *2 AA :ひ一アミラーゼ' * 1 GA: glucoamylase * 3 (alcohol production amount added τ starch amount) X 100 * 2 AA: Hi-amylase '

実施例 1の酵母、 比較例 1〜3の酵母ともに、 デンプンを炭素源として生 育し、 アルコール発酵したことは、 各表層に提示された酵素および分泌され た酵素がデンプンを分角荦してグルコースを生成し、 これが利用されたことを 示している。 Both the yeast of Example 1 and the yeasts of Comparative Examples 1 to 3 grew using starch as a carbon source and fermented with alcohol, because the enzymes presented on each surface layer and the secreted enzymes separated the starch from each other. Glucose was produced, indicating that it was used.

本発明の、 ダルコアミラーゼを G P Iアンカーにより細胞表層に提示し、 α一アミラーゼを分泌する酵母は、 増殖フェーズにおいては、 他の酵母と大 差はなかったものの、 驚くべきことに、 アルコール癸酵の能力が、 他の酵母 に比べて優れていることが見出された (実施例 2 ) 。 すなわち、 他の酵母と 比べて、 デンプンの分角速度が早く、 しかも残存するデンプン量が少なく、 アルコール発酵の速度も大きいことが判明した。 本発明の酵母のアルコール 生産量は、 約 7 7 g/lであり、 添加したデンプンの約 4 0 %がアルコールに 変換されたことになる。 この値は、 グルコースを基質とした場合と遜色なく、 実用性があることが立証された。 なお、 他の酵母のアルコール収率は、 グル コアミラーゼと α—アミラーゼとを G P Iアンカーにより細胞表層に提示す る酵母では 3 4 %、 α—アミラーゼを G P Iアンカーにより細胞表層に提示 し、 ダルコアミラーゼを分泌する酵母では 3 4 %、 ダルコアミラーゼを G P Iアンカーにより細胞表層に提示する酵母では 3 1 %であった。 このことは、 本発明の酵母がデンプンから直接アルコール発酵をするのに適しており、 実 用性が高レ、ことを示している。 The yeast of the present invention, which presents dalcoamylase on the cell surface by means of a GPI anchor and secretes α- amylase, did not differ greatly from other yeasts in the growth phase. The capacity was found to be superior to other yeasts (Example 2). In other words, it was found that, compared to other yeasts, the angular velocity of starch was faster, the amount of remaining starch was smaller, and the speed of alcohol fermentation was higher. The alcohol production of the yeast of the present invention was about 77 g / l, which means that about 40% of the added starch was converted to alcohol. This value proved to be practical, comparable to the case where glucose was used as a substrate. The alcohol yield of other yeasts is 34% for yeast that presents glucoamylase and α -amylase on the cell surface using a GPI anchor, and dalcoamylase is that when α-amylase is presented on the cell surface using a GPI anchor. Was 34% in yeast secreting, and 31% in yeast displaying dalcoamylase on the cell surface by GPI anchor. This indicates that the yeast of the present invention is suitable for performing alcohol fermentation directly from starch and has high practicality.

また、 反応終了後、 実施例 3で用いた本発明の酵母をトリブトファンとゥ ラシルを含まない S D培地で希釈し、 そして Y P Dプレートおよび、 トリプ トフアンとゥラシルを含まない S Dプレートに播き、 30°Cにて 48時間のィン キュベーシヨン後、 両方のプレート上のコロニー数をカウントしたところ、 8 0 %以上の酵母が、 プラスミ ドを安定に保持していた。 (実施例 3 : Rhizopus oryzae由来のダルコアミラーゼを G P Iアンカー により細胞表層に提示しかつ Str印 tococcus bovis由来のひ一アミラーゼを 分泌する凝集性酵母の作成) After completion of the reaction, the yeast of the present invention used in Example 3 was diluted with an SD medium containing no tributophan and peracil, and plated on a YPD plate and an SD plate containing no triptophan and peracil. After incubation for 48 hours at, the number of colonies on both plates was counted. As a result, 80% or more of the yeasts stably retained plasmid. (Example 3: Preparation of flocculent yeast which presents dalcoamylase derived from Rhizopus oryzae on the cell surface with a GPI anchor and secretes Streptococcus bovis-derived human amylase)

Rhizopus oryzae由来のダルコアミラーゼを GP Iアンカーにより細胞表 層に提示するためのプラスミド pGAl 1 i Streptococcus bovis由来のひ 一アミラーゼを分泌するためのプラスミド p SBAA2とを、 実施例 1と同 様に酵母 YF 207に同時に導入し、 得られた酵母を YF 207/ [pGA 1 1, SBAA2] と命名した。  The plasmid pGAl1i for displaying Dalcoamylase derived from Rhizopus oryzae on the cell surface with a GPI anchor and the plasmid pSBAA2 for secreting human amylase derived from Streptococcus bovis were used in the same manner as in Example 1 to obtain yeast YF. At the same time, the resulting yeast was named YF207 / [pGA11, SBAA2].

(比較例 7 : Rhizopus oryzae由来のグノレコアミラーゼおよび S reptococc us bovis由来の α—アミラーゼをそれぞれ GP Iアンカーにより細胞表層に 提示する凝集性酵母の作成) (Comparative Example 7: Preparation of cohesive yeast that presents gnorecoamylase from Rhizopus oryzae and α-amylase from Sreptococcus bovis on the cell surface using GPI anchors, respectively)

Rhizopus oryzae由来のダルコアミラーゼを GP Iアンカーにより細胞表 層に提示するためのプラスミド pGAl 1と Streptococcus bovis由来の α 一アミラーゼを GP Iアンカーにより細胞表層に提示するためのプラスミ ド pBAAlとを、 実施例 1と同様に酵母 YF 207に同時に導入し、 得られ た酵母を YF 207Z [pGAl 1, BAA1] と命名した。  A plasmid pGAl1 for displaying Rhizopus oryzae-derived darcoamylase on the cell surface with a GPI anchor and a plasmid pBAAl for displaying α-amylase from Streptococcus bovis with a GPI anchor on the cell surface were prepared in Examples. The yeast was simultaneously introduced into yeast YF207 in the same manner as in 1, and the resulting yeast was named YF207Z [pGAl1, BAA1].

(比較例 8 : Streptococcus bovis由来の α—アミラーゼを G P Iアンカ 一により細胞表層に提示する凝集性酵母の作成) (Comparative Example 8: Preparation of flocculant yeast that presents α-amylase derived from Streptococcus bovis on the cell surface by GPI anchor)

Streptococcus bovis由来の CK一アミラーゼを G P Iアンカーにより細胞 表層に提示するためのプラスミド pBAAlを、 実施例 1と同様に酵母 YF 207に導入し、 得られた酵母を YF 207/p BAA1と命名した。 8234 Plasmid pBAAl for displaying Streptococcus bovis-derived CK monoamylase on the cell surface with a GPI anchor was introduced into yeast YF207 in the same manner as in Example 1, and the obtained yeast was named YF207 / pBAA1. 8234

28  28

(比較例 9 : Streptococcus bovis由来の α—アミラーゼを分泌する凝集 性酵母の作成) (Comparative Example 9: Preparation of aggregating yeast secreting α-amylase from Streptococcus bovis)

Streptococcus bovis由来の α—アミラーゼを分泌するためのプラスミド P SBAA2を、 実施例 1と同様に酵母 YF 207に導入し、 得られた酵母 を YF 207/p SBAA2と命名した。  Plasmid P SBAA2 for secreting α-amylase derived from Streptococcus bovis was introduced into yeast YF207 in the same manner as in Example 1, and the obtained yeast was named YF207 / pSBAA2.

なお、 実施例 3および比較例 7〜 9で得られた酵母について、 プラスミド pGAl 1によるダルコアミラーゼの細胞表層発現をフローサイトメトリー 分析によって確認し、 そしてプラスミド p BAA 1による細胞表層発現およ ぴ p SBAA2による分泌発現の α—アミラーゼ活性をブルースターチプレ ートによって確認した。  For the yeasts obtained in Example 3 and Comparative Examples 7 to 9, expression of the cell surface of dalcoamylase by the plasmid pGAl1 was confirmed by flow cytometry analysis. The α-amylase activity of secretory expression by SBAA2 was confirmed by blue starch plate.

(実施例 4、 比較例 10〜13) (Example 4, Comparative Examples 10 to 13)

実施例 3、 比較例 3および 7〜 9で得られた形質転換酵母各 200 μ 1を、 5 g/1 D-グルコースを含む 100mlの YSP培地 (lOg/1酵母エキストラクト、 20g/ 1 ポリペプトン、 20g/l蒸煮コーンスターチに接種し、 そして酵母細胞を、 30°Cにて好気的条件下で 48時間振とうしながら培養して、 増殖させた。 結果 を、 図 6に示す。  200 μl of each of the transformed yeasts obtained in Example 3, Comparative Examples 3 and 7 to 9 was added to 100 ml of YSP medium containing 5 g / 1 D-glucose (lOg / 1 yeast extract, 20 g / 1 polypeptone, 20 g / l steamed corn starch was inoculated, and the yeast cells were grown by shaking for 48 hours under aerobic conditions at 30 ° C. The results are shown in FIG.

Streptococcus bovis由来の α—アミラーゼのみを G P Iアンカーにより 細胞表層に提示または分泌する YF 207ΖρΒΑΑ1および YF 207/ p SBAA2は両方とも、 蒸煮コーンスターチを炭素源として増殖し得、 そ して 48時間後に 0D600は 14に達した。 一方、 ダルコアミラーゼ提示酵母 YF 207/pGAl 1は、 わずかに増殖したにすぎなかった。 Streptococcus bovis derived from α- amylase only both YF 207Zetarobetaarufaarufa1 and YF 207 / p SBAA2 presented or secreted to the cell surface by GPI anchor, can grow steaming corn starch as a carbon source, 0D 600 with its after 48 hours Reached 14. On the other hand, the dalcoamylase-presenting yeast YF207 / pGAl1 grew only slightly.

また、 Rhizopus oryzae由来のダルコアミラーゼを GP Iアンカーにより 細胞表層に提示しかつ Streptococcus bovis由来の ο;—アミラーゼを分泌す る YF 207/ [pGAl 1, p S B AA 2 ] は、 蒸煮コーンスターチ培地 で増殖し、 そして 48時間後に 0D6。。は 25に達した。 ダルコアミラーゼおよび 0208234 YF207 / [pGAl1, pSBAA2], which presents Rhizopus oryzae-derived dalcoamylase on the cell surface with a GPI anchor and secretes Streptococcus bovis ο; -amylase, grows on steamed corn starch medium. 0D 6 after 48 hours. . Reached 25. Dalcoamylase and 0208234

29 α—アミラーゼを共提示する YF 207/ [p GA 11 , pBAAl] も、 蒸煮コーンスターチで良好に増殖していた。 これらの 2種の組換え酵母は、 48時間の培養で、 培地中のデンプンの消費量も多かつた。  YF207 / [pGA11, pBAAl] co-presenting 29α-amylase also grew well on steamed corn starch. These two types of recombinant yeast also consumed a large amount of starch in the culture medium after culturing for 48 hours.

次に、 無蒸煮コーンスターチ培地を用いた場合のアルコール発酵について 検討した。 上記 5種の組換え酵母細胞を、 それぞれ 30°Cにて好気的条件下で 48時間、 SDC培地 (適切なアミノ酸およびヌクレオチドを追加した 6.7g/l ye ast nitrogen base, lOg/1 カザミノ酸、 20g/l グルコース) で増殖し、 500 OXgでの 10分間の遠心分離によって回収した。 得られた細胞ペレットを、 50 mlの YPS培地 (lOg/1酵母エキストラクト、 20g/l ポリペプトン、 50g/l 無 蒸煮コーンスターチに、 初期 0D6。。 =60の酵母細胞濃度で接種した。 次いで、 30°Cにて嫌気的条件下で攪拌 (lOOrpm) しながらアルコール発酵を行った。 結果を図 7に示す。 Next, we examined alcoholic fermentation using a non-steamed corn starch medium. Each of the above five types of recombinant yeast cells was cultured under aerobic conditions at 30 ° C for 48 hours in an SDC medium (6.7 g / l yeast nitrogen base, lOg / 1 casamino acid supplemented with appropriate amino acids and nucleotides). , 20 g / l glucose) and harvested by centrifugation at 500 OXg for 10 minutes. The resulting cell pellet, YPS medium 50 ml (lOg / 1 yeast extract, 20 g / l polypeptone, to 50 g / l uncooked corn starch, were inoculated in yeast cell concentration in the initial 0D 6 .. = 60. Then, Alcohol fermentation was performed while stirring (100 rpm) under anaerobic conditions at 30 ° C. The results are shown in FIG.

図 7からわかるように、 50g/lの無蒸煮コーンスターチを炭素源として用 いた場合、 Rhizopus oryzae由来のダルコアミラーゼを提示しかつ Streptoco ecus bovis由来の α—アミラーゼを分泌する YF 207Z [: GA11,  As can be seen from FIG. 7, when 50 g / l of uncooked cornstarch was used as a carbon source, YF207Z that presents Dalcoamylase from Rhizopus oryzae and secretes α-amylase from Streptocoecus bovis [: GA11,

SBAA2] のみが、 デンプンを消費しそしてエタノールを生産し得た。 一 方、 他の組換え酵母細胞では、 エタノールの生産量は非常に少なく、 ほとん ど増殖していなかった。  Only SBAA2] was able to consume starch and produce ethanol. On the other hand, other recombinant yeast cells produced very little ethanol and had little growth.

そこで、 無蒸煮デンプンからエタノールを生産し得る YF 207Ζ CpG Al l, p S BAA 2] を使用して、 アルコール発酵における仕込みデンプ ン濃度の影響を検討した。 なお、 初期 0D60。は 60とした。 図 8に示すように、 仕込みデンプン濃度が高くなるにつれて、 生産されるエタノール濃度が高く なつた。 250g/lの無蒸煮コーンスターチでは約 80時間で 50g/lのエタノール 濃度に達した。 Therefore, the effect of the starch concentration on alcohol fermentation was examined using YF207ΖCpGAll, pSBAA2, which can produce ethanol from uncooked starch. The initial 0D 60. Was set to 60. As shown in Figure 8, the higher the starch concentration, the higher the ethanol concentration produced. In the case of 250g / l uncooked corn starch, the ethanol concentration reached 50g / l in about 80 hours.

さらに、 250g/lの無蒸煮コーンスターチ培地を用いる場合の仕込み時の Y In addition, when using 250 g / l of non-steamed corn starch medium,

F 207/ [pGAl 1, S BAA2] の細胞濃度について検討した。 図 9に示すように、 初期 0D6。。が高くなるにつれて、 初期エタノール生産速度 は上昇するが、 最終エタノーノレ濃度は減少していた。 一方、 初期 0D60O=30 に酵母細胞濃度を低下させると、 エタノール濃度は 60g/lに達したが、 50g/l エタノールに達するまでには、 初期 OD60。 = 60の場合よりも時間を要した。 The cell concentration of F207 / [pGAl1, SBAA2] was examined. Figure Initial 0D 6 as shown in 9. . As the concentration increased, the initial ethanol production rate increased, but the final ethanol concentration decreased. On the other hand, when the yeast cell concentration was reduced to initial 0D 60O = 30, the ethanol concentration reached 60 g / l, but by the time it reached 50 g / l ethanol, the initial OD 60 . = It took longer than 60.

(実施例 5 : R izopus oryzae由来のダルコアミラーゼおよび Streptococc us bovis由来の α—アミラーゼを凝集機能ドメインとの融合タンパク質とし て細胞表層に提示する非凝集性酵母の作成) (Example 5: Preparation of non-aggregating yeast that presents Dalcoamylase from Rizopus oryzae and α-amylase from Streptococcus bovis as a fusion protein with an aggregation function domain on the cell surface)

上記参考例 2の [2- 7 - 7] で得られたプラスミドpWGαGFSAを、 Yea st Maker (Clontech Laboratories, Inc., Palo Alto, CA) を用いた酢酸リ チウム法によって、 非凝集性酵母 S. cerevisiae MT8— 1に導入した。 こ れを、 L一トリプトファンを含まない適切なアミノ酸および塩基を補充した SD— W寒天選択培地 (6.7% Yeast nitrogen base w/o amino acids (Difc o Laboratories製)、 2% グルコース、 2%寒天末) を用いて培養した。 生育 した酵母を選択し、 得られた形質転換体を MT 8— lZpWGaGF S A (ダルコアミラーゼ + α—アミラーゼ融合表層提示酵母) と命名した。 The plasmid pWGαGFSA obtained in [2-7-7] of Reference Example 2 above was non-aggregated yeast S. by the lithium acetate method using Yeast Maker (Clontech Laboratories, Inc., Palo Alto, CA). cerevisiae MT8-1 was introduced. This was purified using SD-W agar selection medium (6.7% yeast nitrogen base w / o amino acids (Difc Laboratories), 2% glucose, 2% agar powder supplemented with appropriate amino acids and bases without L-tryptophan). ). The grown yeast was selected, and the obtained transformant was named MT8-lZpWGaGFSA (Dalcoamylase + α -amylase fusion surface display yeast).

(比較例 14 : Rhizopus oryzae由来のダルコアミラーゼを凝集機能ドメ インにより細胞表層に提示する非凝集性酵母の作成) (Comparative Example 14: Preparation of non-aggregating yeast that presents dalcoamylase derived from Rhizopus oryzae on the cell surface using an aggregation-functional domain)

上記参考例 2の [2-8] で得られた Rhizopus oryzae由来のグルコアミラー ゼを細胞表層に提示するためのプラスミド pWGaGFSを、 実施例 5と同 様に非凝集性酵母 MT 8-1に導入し、 得られた酵母を MT 8- 1/pWG aGFS (ダルコアミラーゼ表層提示酵母) と命名した。 (比較例 15 : Streptococcus bovis由来の α—アミラーゼを凝集機能ド メインにより細胞表層に提示する凝集性酵母の作成) 8234 The plasmid pWGaGFS for displaying the Rhizopus oryzae-derived glycoamylase obtained in [2-8] of Reference Example 2 above on the cell surface was introduced into the non-aggregating yeast MT 8-1 in the same manner as in Example 5. The obtained yeast was designated as MT 8-1 / pWG aGFS (Dulcoamylase surface-displaying yeast). (Comparative Example 15: Preparation of flocculant yeast that presents α-amylase derived from Streptococcus bovis on the cell surface by a flocculant domain) 8234

31 - 上記参考例 2の [2-7-6] で得られた Streptococcus bovis由来の CK一アミ ラーゼを細胞表層に提示するためのプラスミド pWGaFSAを、 実施例 5 と同様に非凝集性酵母 MT 8 - 1に導入し、 得られた酵母を MT 8-1/p WGaF SA (α—アミラーゼ表層提示酵母) と命名した。  31-Plasmid pWGaFSA for displaying Streptococcus bovis-derived CK monoamylase obtained in [2-7-6] of Reference Example 2 above on the cell surface was added to non-aggregating yeast MT8 in the same manner as in Example 5. The resulting yeast was named MT 8-1 / p WGaF SA (α-amylase surface display yeast).

(実施例 6、 比較例 16〜17) (Example 6, Comparative Examples 16 to 17)

上記実施例 5、 比較例 14および 15で得られた形質転換酵母のそれぞれ について、 ダルコアミラーゼ活性についてのプレートアツセィを次のように 行った。 1%酵母エキス、 2%ペプトン、 3%可溶性デンプン、 0.003%プロモクレ ゾールパープル、 0.5%グルコース、 および 2%寒天末からなるプレート培地上 に各形質転換体を画線した後、 30 °Cで 4日間、 次いで 4 °Cで 2日間保存し た。 コロニーの周囲に形成された透明なハロを観察することによって、 グル コアミラーゼ活性を検出した。 この結果を図 10に示す。 ダルコアミラーゼ 表層提示酵母 MT 8— 1/pWGaGF Sおよびダルコアミラーゼ +α—ァ ミラーゼ融合表層提示酵母 ΜΤ 8— 1/pWGaGFSAの周囲にははつき りした透明なハ口が観察されたことから、 これらが十分なダルコアミラーゼ 活性を有することがわかった。 また、 α—アミラーゼ表層提示酵母 MT 8— l/pWGひ F SAの周囲には、 かすかにハ口の形成が見られたことから、 微弱ながらグノレコアミラーゼ活性を有していた。  For each of the transformed yeasts obtained in Example 5 and Comparative Examples 14 and 15, a plate assay for dalcoamylase activity was performed as follows. After streaking each transformant on a plate medium consisting of 1% yeast extract, 2% peptone, 3% soluble starch, 0.003% promocresol purple, 0.5% glucose, and 2% agar powder, streak at 30 ° C. For 2 days and then at 4 ° C for 2 days. Glucoamylase activity was detected by observing a clear halo formed around the colony. The result is shown in FIG. Dalcoamylase Surface-displaying yeast MT8-1 / pWGaGFS and Darcoamylase + α-amylase fusion surface-displaying yeast ΜΤ 8-1 / pWGaGFSA Was found to have sufficient dalcoamylase activity. In addition, yeast cells displaying α-amylase on the surface of MT8-1 / pWG and FSA showed faint mouth formation.

(実施例 7、 比較例 18〜19) (Example 7, Comparative Examples 18 to 19)

上記実施例 5、 比較例 14および 15で得られた形質転換酵母のそれぞれ について、 α—アミラーゼ活性のプレートアツセィを以下のように行った。 1%酵母エキス、 2%ペプトン、 0.25%レマゾールデンプン、 2%グルコース、 お よび 2%寒天末からなるプレート培地上に各形質転換体を画線した後、 30 °C で 4日間培養した。 コロニーの周囲に形成された透明なハロを観察すること によって、 α—アミラーゼ活性を検出した。 この結果を図 11に示す。 α— アミラーゼ表層提示酵母 Μ Τ8— 1/pWGaFSAおよぴグルコアミラー ゼ + α—ァミラーゼ融合表層提示酵母 MT 8— lZpWGoiGFSAの周囲 には、 はっきりした透明なハ口が観察されたことから、 これらが十分な α— アミラーゼ活性を有することがわかる。 また、 ハ口の大きさからわかるよう に、 ダルコアミラーゼ +α一アミラーゼ融合表層提示酵母は、 α—アミラー ゼ表層提示酵母よりも活性が高かった。 これは、 2種のァミラーゼを融合発 現させることが有用であることを示す。 For each of the transformed yeasts obtained in Example 5 and Comparative Examples 14 and 15, a plate assay for α-amylase activity was performed as follows. Each transformant was streaked on a plate medium consisting of 1% yeast extract, 2% peptone, 0.25% remazole starch, 2% glucose, and 2% agar powder, and then cultured at 30 ° C for 4 days. Observing a clear halo formed around the colony As a result, α-amylase activity was detected. The result is shown in FIG. α-amylase surface-displaying yeast Τ 8-1 / pWGaFSA and glucoamylase + α-amylase fusion surface-displaying yeast MT8-lZpWGoiGFSA It can be seen that it has an α-amylase activity. Also, as can be seen from the size of the mouth, the yeast displaying the surface of the dalcoamylase + α- amylase fusion surface was higher in activity than the yeast displaying the surface of the α- amylase. This indicates that fusion expression of the two amylases is useful.

(実施例 8) (Example 8)

実施例 5で得られた形質転換酵母 200^1を、 5g/l D-グルコースを含む 10 0mlの YSP培地 (lOg/1酵母エキストラク ト、 20g/l ポリペプトン、 20g/l 蒸 煮コーンスターチに接種し、 そして酵母細胞を、 30°Cにて好気的条件下で 48 時間振とうしながら培養して増殖させると、 デンプンを消費しそしてェタノ ールを生産する。  200 ml of the transformed yeast obtained in Example 5 was inoculated into 100 ml of YSP medium containing 5 g / l D-glucose (10 g / l yeast extract, 20 g / l polypeptone, 20 g / l steamed corn starch). The yeast cells are grown and grown at 30 ° C with shaking under aerobic conditions for 48 hours, consuming starch and producing ethanol.

産業上の利用可能性 Industrial applicability

本発明の、 ダルコアミラーゼを表層に提示し、 かつ α—アミラーゼを分泌 する酵母は、 デンプンを基質として生育する場合、 ダルコアミラーゼと α— アミラーゼをそれぞれ細胞表層に提示する酵母、 α—アミラーゼを細胞表層 に提示しダルコアミラーゼを分泌する酵母、 およぴグルコアミラーゼを細胞 に提示する酵母と大差はないが、 デンプンからのアルコール発酵の能力が、 他の酵母に比べて優れている。 そのアルコールの収率は 40%と、 ダルコ一 スからのアルコール発酵と遜色ないため、 デンプンから直接エタノールを生 産するために有用である。 特に、 分泌させる α—アミラーゼとして Streptoc occus bovis由来のものを用いると、 無蒸煮デンプンを炭素源とした場合で も高収率でのアルコール生産が可能である。 したがって、 生デンプンを蒸煮 することなく、 より効率的にエタノールを生産できる。 また、 ダルコアミラ ーゼ + α—ァミラーゼ融合表層提示酵母も、 デンプンを効率よくアルコール 発酵させる能力を有するため、 デンプンからの直接的なエタノール生産に有 用である。 The yeast of the present invention, which presents dalcoamylase on the surface and secretes α-amylase, is a yeast which presents dalcoamylase and α-amylase on the cell surface, respectively, when grown using starch as a substrate. Yeast that presents dalcoamylase on the surface and secretes glucoamylase, and yeast that presents glucoamylase to cells are not much different, but have higher alcohol fermentation ability from starch than other yeasts. Since the alcohol yield is 40%, which is comparable to alcohol fermentation from Darcos, it is useful for producing ethanol directly from starch. In particular, when α-amylase derived from Streptococcus bovis is used for secretion, it is possible to use uncooked starch as a carbon source. Can also produce alcohol in high yield. Therefore, it is possible to produce ethanol more efficiently without cooking raw starch. In addition, dalcoamylase + α-amylase fusion surface-displaying yeast also has the ability to efficiently ferment starch with alcohol, and is therefore useful for direct ethanol production from starch.

Claims

請求の範囲 The scope of the claims 1. ダルコアミラーゼを細胞表層に提示し、 かつ 一アミラーゼを分泌する 酵母。 1. A yeast that displays dalcoamylase on the cell surface and secretes an amylase. 2. 前記ダルコアミラーゼが、 GP Iアンカーを介して提示されている、 請 求項 1に記載の酵母。 2. The yeast of claim 1, wherein said dalcoamylase is presented via a GPI anchor. 3. 前記ダルコアミラーゼが、 G P Iアンカー付着認識シグナル配列を有さ ない糖鎖結合タンパク質ドメインとの融合タンパク質として提示されている、 請求項 1に記載の酵母。 3. The yeast according to claim 1, wherein the dalcoamylase is presented as a fusion protein with a sugar chain binding protein domain having no GPI anchor attachment recognition signal sequence. 4. ダルコアミラーゼおよび α—アミラーゼを、 GP Iアンカー付着認識シ グナル配列を有さない糖鎖結合タンパク質ドメインとの融合タンパク質とし て細胞表層に提示する酵母であって、 該ドメインの一端に該グルコアミラー ゼが融合され、 そして他端に該 α—アミラーゼが融合されている、 酵母。 4. A yeast which presents dalcoamylase and α-amylase to the cell surface as a fusion protein with a sugar chain binding protein domain having no GPI anchor attachment recognition signal sequence, wherein the glucoamylase is located at one end of the domain. A yeast, wherein the α-amylase is fused to the other end. 5. 前記糖鎖結合タンパク質ドメインが、 少なくとも GP Iアンカータンパ ク質の凝集機能ドメインを含む部分である、 請求項 3または 4に記載の酵母。 5. The yeast according to claim 3, wherein the sugar chain binding protein domain is a portion containing at least an aggregation functional domain of a GPI anchor protein. 6. 前記 GP Iアンカータンパク質が、 凝集タンパク質である、 請求項 5に 記載の細胞表層結合性タンパク質。 6. The cell surface binding protein according to claim 5, wherein the GPI anchor protein is an aggregated protein. 7. 前記凝集タンパク質が、 FL01、 FL02、 FL04、 FL05、 F L09、 FLO10、 および FLOl 1からなる群より選択されるタンパク 質である、 請求項 6に記載の細胞表層結合性タンパク質。 7. The cell surface-binding protein according to claim 6, wherein the aggregated protein is a protein selected from the group consisting of FL01, FL02, FL04, FL05, FL09, FLO10, and FLO11. 8 . 前記 α—アミラーゼが Streptococcus bovis由来である、 請求項 1から 7のいずれかに記載の酵母。 8. The yeast according to any one of claims 1 to 7, wherein the α-amylase is derived from Streptococcus bovis. 9 . 請求項 1から 8のいずれかに記載の酵母を、 デンプンを含む培地で培養 する工程を含む、 アルコールの製造方法。 9. A method for producing alcohol, comprising a step of culturing the yeast according to any one of claims 1 to 8 in a medium containing starch. 1 0 . 前記デンプンが無蒸煮である、 請求項 9に記載の方法。 10. The method of claim 9, wherein the starch is uncooked.
PCT/JP2002/008234 2001-08-16 2002-08-12 Process for producing alcohol from starch Ceased WO2003016525A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003521834A JP4189317B2 (en) 2001-08-16 2002-08-12 Process for producing alcohol from starch

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2001-247134 2001-08-16
JP2001247134 2001-08-16
JPPCT/JP02/01980 2002-03-04
PCT/JP2002/001980 WO2003016524A1 (en) 2001-08-16 2002-03-04 Process for producing alcohol from starch

Publications (2)

Publication Number Publication Date
WO2003016525A1 WO2003016525A1 (en) 2003-02-27
WO2003016525A9 true WO2003016525A9 (en) 2003-10-16

Family

ID=26345146

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/008234 Ceased WO2003016525A1 (en) 2001-08-16 2002-08-12 Process for producing alcohol from starch

Country Status (1)

Country Link
WO (1) WO2003016525A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1678314T3 (en) * 2003-10-22 2013-02-28 Keck Graduate Inst Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy
JP4665989B2 (en) 2008-04-10 2011-04-06 株式会社豊田中央研究所 Acid-resistant endoglucanase and its use
JP2011092041A (en) * 2009-10-28 2011-05-12 Kansai Chemical Engineering Co Ltd Apparatus for continuously culturing and fermenting ethanol-producing microorganism
JP2011182644A (en) * 2010-03-04 2011-09-22 Kaneka Corp Method for producing glutathione
JP5626854B2 (en) * 2010-06-08 2014-11-19 国立大学法人神戸大学 Ethanol production method
JP2013142170A (en) * 2012-01-11 2013-07-22 Nippon Telegr & Teleph Corp <Ntt> Method for preventing hydrogen embrittlement
JP2013142171A (en) * 2012-01-11 2013-07-22 Nippon Telegr & Teleph Corp <Ntt> Method for preventing corrosion of metal
JP5749690B2 (en) * 2012-06-25 2015-07-15 日本電信電話株式会社 Anticorrosion method for metal structures
US9816113B2 (en) 2013-09-04 2017-11-14 Kansai Chemical Engineering Co., Ltd. Method for producing ethanol
KR102256699B1 (en) * 2019-11-07 2021-05-27 강원도 New Saccharomyces cerevisiae strain having high flocculation and fermentation ability and alcoholic beverages comprising the same

Also Published As

Publication number Publication date
WO2003016525A1 (en) 2003-02-27

Similar Documents

Publication Publication Date Title
CN107586789B (en) High-yield acidic protease aspergillus niger recombinant expression strain and construction method and application thereof
Nagodawithana et al. Yeast selection for baking
CN106701606B (en) Genetic engineering candida utilis capable of degrading and utilizing kitchen waste and construction method thereof
CN106754466A (en) It is a kind of for efficient exogenous protein expression and the bacillus subtilis of High Density Cultivation
JP5350806B2 (en) System for producing aromatic molecules by biotransformation
CN106755015B (en) Novel pullulanase gene, method for obtaining high-yield strain and enzyme production process
JPH05184352A (en) Method for expressing dissimilar gene in pichia pastoris yeast, expression vector and transforming microorganism
JP2021514679A (en) Recombinant oxalate decarboxylase expressed by filamentous fungal host cells
CN114107146B (en) Construction method and application of resistance-marker-free auxotroph bacillus subtilis
WO2003016525A9 (en) Process for producing alcohol from starch
CN108603186B (en) Yeast strain co-expressing exogenous saccharifying enzyme, method for obtaining yeast strain and application of yeast strain in production of bioethanol
He et al. Direct production of ethanol from raw sweet potato starch using genetically engineered Zymomonas mobilis
CN103695388B (en) α-amylase and Aspergillus niger strain expressing α-amylase
CN107058263B (en) Efficient preparation method of novel beta-amylase
CN101532028A (en) Method for breeding high-yield glucoamylase industrial production strains
US12203111B2 (en) Materials and methods for creating strains of Saccharomyces cerevisiae that exhibit an increased ability to ferment oligosaccharides into ethanol
CN102925420B (en) A kind of α-amylase and recombinant strain expressing α-amylase
CN102994475A (en) Alpha-amylase and recombinant strain for expressing alpha-amylase
CN115948265B (en) Kluyveromyces marxianus haploid yeast and construction method and application thereof
JP4189317B2 (en) Process for producing alcohol from starch
CN117187084A (en) Method for recombinant expression of basidiomycete laccase by aspergillus niger
Ibragimova et al. A strategy for construction of industrial strains of distiller's yeast
JP4666884B2 (en) Method for producing ethanol from starch
JP2001238665A (en) Practical baker&#39;s yeast with high amino acid accumulation
Yin et al. Construction of a shuttle vector for heterologous expression of a novel fungal α-amylase gene in Aspergillus oryzae

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
COP Corrected version of pamphlet

Free format text: PAGE 9/10, DRAWINGS, ADDED

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2003521834

Country of ref document: JP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase